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ABSTRACT
Alterations in Intrinsic Heart Rate in Endotoxemia
Peter D. Wearden

After much early debate, it is now well recognized that the origin of the heart beat
is myogenic, or intrinsic, to the heart. It has been felt that the intrinsic heart rate (IHR) is
constant and that the observed heart rate is controlled by tonal alterations in the activity
of the autonomic nervous system in response to various stimuli. Some investigators have
recognized, however, that the intrinsic heart rate (IHR) can be altered in certain
conditions. Sepsis, or the host response to bacterial infection, is recognized as a stress to
the host that results in decreased myocardial contractility and tachycardia. Some
previous work has suggested that this tachycardia may exist outside the tonal regulation
of the autonomic nervous system, raising the possibility of an elevation of the IHR.
Utilizing an E. coli lipopolysaccharide (LPS) endotoxin model of sepsis in the rat, this
work demonstrates an elevation of the IHR in sepsis. The experimental evidence further
suggests that the β-adrenoceptor participates in the induction of the elevation in IHR
early in the septic process. By sixteen hours after LPS administration the β-adrenoceptor
is, however, no longer required for the ongoing elevation of IHR. It is also demonstrated
that the elevation in IHR is more prolonged than the contractile dysfunction induced by
LPS.
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INTRODUCTION
The aging of our population, coupled with advances in life supporting technology,
surgical techniques and pharmaceuticals have markedly advanced our ability to care for the
critically ill, and thereby increased the severity of illness seen in the average patient. The
increased degree of illness and invasiveness of therapy leaves these patients particularly
susceptible to the development of infection. As the numbers of these patients and the length
of their hospitalizations have increased, sepsis, or the overwhelming response to bacterial
infection has dramatically increased. Discharge surveys over the 1980s recorded a 139%
increase in the discharge diagnosis of septicemia. Sepsis is now the most common cause of
death in intensive care units, and is the 13th most common cause of death in the United
States. At this time there are estimated to be 400,000 cases of sepsis and 200,000 episodes of
septic shock annually, resulting in 100,000 deaths. The overall cost to the American
economy is estimated at ten to 15 billion dollars per year (Bone et. al., 1992; Parrillo 1990;
Quartin, 1997).
With the greater recognition of sepsis as a disease entity, research into its causes and
treatment has also grown. In an attempt to better organize this research, in 1992 the
American College of Chest Physicians / Society of Critical Care Medicine Consensus
Conference Committee proposed a standardization of terminology pertaining to sepsis and
the host response to infection (Bone et. al., 1992).
Systemic inflammatory response syndrome (SIRS): SIRS is characterized by two or more
of the following: (1) temperature greater than 38° C or less than 36°; (2) heart rate greater
than 90 beats per minute; (3) respiratory rate greater than 20 breaths per minute, or a
PaCO2 less than 32 mmHg; and (4) white blood cell count greater than 12, 000 per cubic
mm, less than 4,000 per cubic mm, or greater than 10% band [immature] forms.
Sepsis: The presence of SIRS in association with culture proven infection.

1

Septic shock: Sepsis with hypotension despite adequate fluid resuscitation, along with
the presence of manifestation of hypoperfusion, including, but not limited to, lactic
acidosis, oliguria, or an acute alteration in mental status.
Multiple organ dysfunction syndrome (MODS): The presence of altered organ function
in an acutely ill patient such that homeostasis cannot be maintained without intervention.

This document discarded the terms septicemia, which had referred to the presence of bacteria
or their toxins in the blood, and bacteremia which refers to the presence of bacteria in the
blood.
As now defined, sepsis, the host response to bacteria and their toxins, includes alterations
in temperature regulation, tachycardia, tachypnea and changes in the white blood cell
population (Natanson et. al., 1995). All of these findings can be made with or without the
presence of live bacteria in the blood and can be precipitated by bacterial endotoxin (Bone
1992).
Despite the presence of normal to often supranormal cardiac outputs, myocardial
dysfunction plays a paramount role in the outcome of patients with septic shock. After some
initial debate, the existence of myocardial dysfunction throughout the septic process has now
been confirmed and extensively studied in both human (Bunnell and Parrillo 1996) and
animal models (Abel 1993) utilizing a variety of techniques. It is now generally believed that
the heart is one of the first organs to fail in MODS. Although, as delineated in the definition
of sepsis, tachycardia is easily and nearly always observed, in this disease state, very little
research has focused on its origin and effect. This is not surprising because it is widely
recognized that tachycardia is an integral part of the autonomic response of a challenged or
stressed host, and sepsis certainly represents a formidable stress on the organism.
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To properly study the dysfunction of the heart one must clearly understand the
function of the heart. Perhaps William Harvey stated it best when he noted, “it has been
shown by reason and experiment that blood by the beat of the ventricles flows through the
lungs and heart and is pumped to the whole body … This is the only reason for the motion of
and the beat of the heart.” (Harvey, 1628). Since this time, recognition of the heart as a
pump is unequivocal. The mechanical nature of the heart has allowed for a wide range of
scientific investigations, and mathematical calculations of its ability to do work. With
advances in molecular biology, gene expression and manipulation, and cellular biochemistry,
the complexity of our understanding of cardiac function increases daily. This scientific
progress not withstanding, the ultimate function of the heart is no more complicated than in
the times of Harvey, its purpose is simply to pump blood to the rest of the body.
The measurement of the capabilities of any pump can be recorded by its outflow. In
the case of the heart the simplest measure of outflow, and therefore pump function, is the
cardiac output (CO). Cardiac output is comprised of the stroke volume (SV) multiplied by
the heart rate (HR). The SV (amount of blood pumped in a single stroke) is determined by
the initial tension on the muscle (preload), described by the Frank-Starling law of the heart,
the opposing force which the heart must pump against (afterload) and the inherent contractile
properties of the heart muscle (inotropy) (Braunwald, 1971). While the interaction between
preload, afterload and the inotropic state of the myocardium complicate the study of the
stroke volume, determination of heart rate, an equally important determinant of CO, is much
less complicated. At the close of the 20th century the thrust of scientific exploration is now at
the level of the cell and molecule. On this level there is no argument that the rate of passage
of ions across the membrane of sinoatrial node cells ultimately determines the rate at which
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the heart beats (Berne and Levy, 1997; Katz, 1992). When examining the heart rate of a
patient or scientific subject, however, the cellular basis of the heartbeat is of less import, as it
is generally felt that the ultimate regulation of heart rate is under the modulatory control of
the autonomic nervous system via sympathetic and parasympathetic input to the heart (Levy,
1979; Randall, 1984).
Taken as outlined above, the role of the autonomic nervous system is to increase the
heart rate in order to augment cardiac output on those occasions when the organism has an
increased demand for oxygenated blood. As demonstrated by the “fight or flight” response
to stressful situations, tachycardia is a predominant feature of this autonomic response. After
the stressful situation is resolved the heart rate returns to normal. Sepsis provides another
example of a stress on the organism that elevates the heart rate. Considering sepsis as an
experimental model of compensatory tachycardia, this dissertation seeks to examine some
fundamental, and in the author’s opinion overlooked, questions with regard to the tachycardic
response. Is the tachycardia of sepsis no more complicated than a simple up and down
regulation via the autonomic nervous system? Can the heart alter its own internal firing rate
in response to certain situations or is it merely subservient to the autonomic nervous system,
and dependent upon its continual tonal regulation? Is tachycardia solely a compensatory
mechanism for the organism, or as is the case in other systems (such as in the inflammatory
response (Bone, 1996)), can the uncontrolled compensation itself become pathology?
Initially the historical development of our current understanding of the regulation of heart
rate and its role in pump function will be examined. An examination of previous thought on
the heart’s ability to regulate itself follows. An overview of the extensive work regarding
cardiac function in sepsis and a brief discussion of the force-frequency relationship concludes
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the background remarks. Then focusing on a model of prolonged myocardial stress, the host
response to gram negative infection, the question as to whether the intrinsic rate of the heart
can be altered, a mechanism by which this occurs, and the potential impact of such an
adaptation will be addressed experimentally.
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Historical Observations on Heart Rate
Returning to William Harvey’s observation that the pumping of blood was “the only
reason for the motion of and the beat of the heart” the emphasis here has been added, but it
was certainly implied by Harvey. Prior to the publication of his treatise the function of the
heart carried other significant connotations including being the seat of the soul, the source of
all thought and emotion, and the very vital force that was life itself.
The earliest recorded observations of what may now be the most common diagnostic
maneuver, the observation of the pulse or heart rate, are contained in the Edmund Smith
Surgical Papyrus. Imhotep [c. 2980 BC] the ancient Egyptian surgeon is recorded observing
the pulse of a trauma victim. “Our ancient surgeon… probes with his fingers to the interior
and discovers cardiac pulsation, or as he says the ‘fluttering and throbbing like that on the
crown of an infant’s head before it has grown together.’” Imhotep, according to the papyrus,
uses this simple observation of the rapidity with which the heart is beating to draw clinical
conclusions. “In observing the pulse our surgeon knows that he is examining the operation
of the heart, and he states that the observation of the pulse is undertaken ‘in order to know
the action of the heart’” (Breasted, 1930).
At this time the historical record is open as to whether Imhotep’s recognition of the
utility of the measurement of heart rate was propagated, or much less likely, lost for the
better part of the next three millennia. What is known, is that by the dawn of Western
civilization, the beating of the heart had taken on a metaphysical nature that would both
hinder and invigorate subsequent study of the heart and circulation. In fact, today 5000
years after Imhotep’s purely physiologic observation, we are reminded every February that
for centuries “matters of the heart” involved much more than the matter of the heart.
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Curiosity with the origin and nature of the beating heart is evident in the writings of
Hippocrates [460 – 375 BC], a teacher at the medical school in Cos, and often considered the
father of medicine. He noted,
”Within the heart there burns a sort of vestal fire, so subtle that it escapes
immediately through any incision made to reveal it. Air coming into the heart from
the trachea and lungs falls upon the flame and is set into a violent effervescence
which drives it out through the opening of the great arteries and at the same time
causes the swelling known as diastole” (Hoff, 1936).
These notions of fire and air conformed nicely to the contemporary concepts as to the nature
of existence. Across ancient Greece at another medical school, Aristotle [384-322 BC] ,
Plato’s greatest student, subsequently undertook the study of the beating heart. (An
argument may be made here to consider Aristotle “the First Investigator” of the heart beat as
he provided us with the foundations of the scientific method.) Applying the scientific
process to the heart beat of embryos (as would many others), and of grown animals, he made
essentially three observations. First, in the chick embryo the beating heart is visible by three
days of age, much earlier than the development of any of the nervous system (Adelman,
1942). Secondly, the heart is the last organ to stop working at death (ultimum moriens). The
third was a simple observation, that the heart was in the center of the body, and therefore
central to all other bodily functions. From these experiments Aristotle drew the conclusion
that the heart is the seat of life. Coupling this with the knowledge that heartbeat changed,
qualitatively and quantitatively, with emotion he extended this conclusion to include the
heart being the center of all human emotion (Doby, 1963). Beyond this Aristotle largely
concurred with Hippocrates’ opinion that the heart contained a motive force, or fire, that
propelled “life” throughout the body. Herophilus [b 330 BC], the grandson of Aristotle, and
student of Praxagoras at Cos is credited with advancing the use of the pulse to diagnose
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disease by studying its rate, strength and rhythm. He subsequently expounded on this theory
to include all manner of oddities including the relationship of the heart beat to music
(Seeman, 1961). Erasistratus [310 – 260 BC], a comtemporary of Herophilus, viewed this as
nonsense and the “cult of the pulse.” It was Erasistratus, however, when called to see
Seleucus Nicator, the son of the Macedonian General Antiochus who had taken ill, made, at
the time, one of the most notable diagnoses using the pulse. Observing a noticeable
quickening of the pulse rate when the boy’s stepmother entered the room, Erasistratus made
the diagnosis. The boy was attracted to his young step-mother and his illness, brought on by
this forbidden love, was betrayed by the “lovers pulse”. Both son and step-mother were
exiled and married and the heart rate took on additional importance (Doby, 1963; Seeman,
1961). Galen [131-201 AD] advanced the cause of the pulse rate as a diagnostic method,
checking the pulse to determine the health of patients and the veracity of their statements.
By this point there was great curiosity about the heart beat, and its diagnostic utility was now
recognized. The explanation of its origin, however, clearly still rested in the metaphysical.
During the early sixteenth century alchemy was the theoretical paradigm to which
most physiological observations had to conform. Sylvius [1478 – 1555], an alchemist,
modified the notion of the “vestal fire” as the causative agent of heart beat. He proposed
that the origin of the heart beat occurred when the alkaline venous blood met up with the
acidic chyle, and bile, resulting in an “effervescence” which caused diastole (Brooks, 1972).
This hypothesis was obviously somewhat problematic, and later Booerhaave [1668 – 1738] is
said to have noted that, “the blood is not alkaline, nor the chyle or gall acid, and even if they
were mixed together no effervescence would take place, and further they never did come
together in the heart” (Hoff, 1936). Some time later, Richard Lower [1631-1691], who
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would make the first observations related to gas exchange in lungs, conducted an experiment
to disprove the hypothesis of Sylvius, that some chemical nature of the blood caused the
heart to beat, by replacing the blood with another fluid.
“With this object in mind I drew off through the jugular vein of a Dog almost half of
its total blood volume, injecting instead through the crural vein an equal amount of
beer mixed with a little wine. This procedure I repeated several times in succession
until, instead of blood, the fluid coming from the vein was merely a solution with less
colour than the washings of meat, or than claret several times diluted. The Heartbeat,
meanwhile, became only slowly more feeble, so that practically the whole of the
blood was replaced by beer before life was replaced by death” (Hoff, 1936).
Although a fascinating way to introduce beer into the laboratory, this particular
experiment of Lower’s was less than pivotal in our current understanding of the heartbeat and
circulation.
William Harvey [1578-1657], on the other hand, with the publication of his treatise,
Excercitatio Anatomica de Motu Cordis et Sanquinis in Animibalis in 1628, laid the
groundwork for our current understanding of the circulation. In reviewing Harvey’s work in
the context of the political nature of science at the time, it becomes apparent that in addition
to being a talented scientist, Harvey must also have had a certain amount of political savvy.
Harvey seems to have recognized that, because of the functions attributed to the heart by
Aristotle and those who followed, the nature of why the heart beats had enormous religious
and therefore political implications. Rather than further breach this interface between
religion and science Harvey makes the simple statement “The heart is fashioned with
appropriate structures for motion, as an internal organism before the body. Being finished
first, Nature wished the rest of the body to be made, nourished and perfected by it, as its
work and home.” He continues, in what is certainly a not so subtle acknowledgement of the
“funding agencies” of the time, “The heart is like the head of state holding supreme power,
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ruling everywhere” (Harvey, 1628). Harvey’s tact allowed for the dissemination of his ideas
about the circulation, and while it is clear that he recognized the heart to be a pump to
nourish the rest of the body with blood, it is unclear how far he intended to distance himself
from the physiology of Aristotle and Galen (Webster, 1965). Along these lines it should be
noted that in this treatise Harvey makes no further observations on the question of precisely
why and how the heart beats.
Less than 50 years later the why of the heart beat again became a contentious issue.
Thomas Willis [1621-1675] rationalized that if the heart was a muscle, which it clearly
appeared to be, and from his study of anatomy it was known that muscles contracted as a
result of nervous stimulation, the origin of the heart beat must therefore be nervous in nature.
Willis did recognize that man could not consciously control the heart, but proposed that this
was because the nerves to the heart originated in the cerebellum and the voluntary nerves of
the skeletal muscle had their origins in the cerebrum (Hoff, 1936). The idea that the heart
beat had its origins in the brain subsequently came to be known as the “neurogenic theory”
and had a number of supporters. One such scientist, John Mayow [1643 – 1679] proposed
that because the dura mater was observed to be pulsatile that this was the origin of the
heartbeat. He went so far as to write, of the dura mater, “I can imagine nothing else but that
this membrane like all others, is intended for the production of motion” (Mayow, 1674).
Fortunately for Mayow, his observations that air consisted of two gases, one of which, later
to be known as oxygen, supported life and turned the blood red, assured his place in the
history of science.
There was, however, an accumulation of data that clearly demonstrated that the heart
could beat regardless of nervous input. One investigator (Boyle) had kept a chick alive for
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two hours after its head had been cut off, and another (Redi) removed the entire brain of a
tortoise in November and it lived until the following May. Another scientist (Savolius)
reported on the chick embryo, “… by the third day of incubation there is hardly a visible
vestige of a brain in a chicken; nevertheless the movement of the heart is clearly noticed; it
could hardly be attributed to the nerves” (Hoff, 1936). Albrecht von Haller [1708 – 1777]
concurred, teaching in his seminal lectures on physiology, that while the nerves may play
some role, “there is still other causes besides than that of the nerves conducing to the motion
of the heart.” In discussing why the “heart never ceases from its perpetual motion”, he notes,
“But to me the simplicity of nature seems very great in this matter, when the auricle is
relaxed, it is directly filled by the muscular force of the continuous great vein, and so
the heart also contracts itself, when, in like manner, it is irritated by the blood driven
into it from the auricle” (Haller, 1777).
Haller then clearly viewed “mobility is inherent to the heart” and he felt that the origin of the
heartbeat was due to irritation of the blood entering the heart. Bolstered by the teachings of
Haller, investigators presented a mounting body of evidence as to the myogenic origin of the
heart beat. In a historical review Fye notes,
By the middle of the 19th century, most investigators had concluded that, like skeletal
muscle, heart muscle would respond to a wide variety of stimuli such as heat, cold,
trauma, and electricity.” (Fye, 1987).
Although these developments recognized the origin of heart rate to be within the heart
there was no consideration as to whether the heart itself could change its rate. The work of
the Webers (inhibitory action of the vagus), Bezold (accelerator nerves), as well as Cannon
(adrenergic factors) and Loewi (cholinergic influences) in recognizing the extrinsic
influences on heart rate are well chronicled (Leake, 1962). During this same time period
scientists, such as Johannes Muller, Robert Remak and Carl Ludwig, had discovered ganglia
within the heart. Muller, among others, put forth the notion that the origin of the heart beat
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rested within these ganglia. This view point provided for the intrinsic nature of the heart beat
but allowed the ultimate causation to be neurogenic in origin (Fye, 1987).
It was the laboratories of Michael Foster and his student Walter Gaskell that
ultimately determined that rythmicity was a property of cardiac muscle and not nervous in
nature. Foster commented upon the thought of those who felt that cardiac ganglia initiated
the heart beat,
“Now when a physiologist in his searching after the hidden cause of some secret
motion finds a ganglion, he cries ‘Eureka!’ and generally folds his hands as if his
work were done. In the case of the heart, however, we may venture to go a little
further and ask the question: in what way or by what means are these ganglia the
cause of the heart’s spontaneous beat? “ (Geison, 1978)
Foster and his pupils through a series of experiments set out to answer this question. Gaskell
ultimately conducted a series of experiments with the tortoise heart demonstrating the
property of automaticity in the different regions of the heart by applying heat to see if the rate
increased. His experiments lead him to determine that automaticity is myogenic in origin,
and that the area of the heart with the greatest automaticity is the sinus venosus. It is
important to note, however, that Gaskell observed automaticity from all regions of the
tortoise heart including the ventricle.
“The automatic rhythm of the ventricle is of the same kind as that of the auricle, and
therefore the sinus, so that if the latter is due to the presence of motor ganglia so too
is the former, and on the other hand, if the former be due to some inherent rythmical
property of the ventricular muscle, then the latter is due to somewhat better
development of the same kind of property in the muscular tissue of the sinus.”
(Gaskell, 1881)
This agreed with Stannius’ [1808-1883] earlier work using ligatures to isolate various parts
of the beating heart. Now an understanding of Haller’s observation of the beating chick
embryo at 45 hours of incubation (as did Aristotle, Harvey and Saviolus before him) and
Schnek’s demonstration that when he removed the heart of a three day old chick embryo and
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kept it beating outside the body, he could increase the heart rate by increases in temperature
(for a review see, Patten, 1949) was no longer dependent upon the unlikely presence of
ganglia for an explanation but rested upon the intrinsic rythmicity of all cardiac cells.
Together, these findings firmly established that the heart beat was “myogenic” in origin and
originated in the area of the great veins (primum movens) (Eyster and Meek, 1921; Brooks,
1972). The distinction that the rythmicity of the heart originated from cardiac cells rather
than ganglion cells was an important advance. The precise location of these pace
determining cells of the mammal, the analog of the sinus venosus, was not described until
1907 when Keith and Flack (as part of Flack’s medical school summer research project
(Brooks, 1972)) published their findings describing the sinoatrial node as where “the
dominating rhythm of the heart normally begins” (Keith and Flack, 1907). The automaticity
of the heart was now recognized as originating in the heart itself. As Patten notes, “the
excision and transection experiments reviewed make the primary myogenic character of the
pulsation so clear that belaboring of this old issue is uncalled for” (Patten, 1949). The heart
rate, however, was recognized to be modulated, if not entirely controlled by, extrinsic
factors, ultimately to be known as the autonomic nervous system (Braunwald, 1974). The
question of whether the heart can alter its “myogenic” rate remains to be answered.
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Intrinsic Cardiac Rate Regulation
Any student of cardiac function quickly recognizes that while the heart beat is
myogenic in origin, the regulation of its rate falls under the auspices of the autonomic
nervous system. Briefly, the autonomic nervous system consists of two major divisions, the
parasympathetic and the sympathetic. The parasympathetic preganglionic nerve cell bodies
lie in the vagal motor nuclei of the brainstem. Passing via the vagus nerve they synapse on
the postganglionic nerve cell bodies resting within the walls of the heart (generally regarded
as a fat pad immediately adjacent to the heart). Neurotransmission at this point occurs via
acetylcholine binding at nicotinic receptors. The postganglionic cells project to the sinoatrial
(SA) and atrioventricular (AV) nodes. Again utilizing acetylcholine as a transmitter, this time
at muscarinic receptors, the function of the parasympathetic nervous system is to cause an
immediate slowing of heart rate. This bradycardia is due to a change in ion channel states
that both hyperpolarize and decrease the upstroke of the cardiac action potential. The
sympathetic preganglionic nerves originate in the spinal cord from C7 to T6. These cells
have a short projection to the paravertebral ganglia where they synapse on the postganglionic
cell bodies, again utilizing nicotinic receptors. The postganglionic axons travel via the great
vessels of the heart to reach both the conducting system of the heart, as well as, the
ventricular muscle. Their nerve terminals release norepinephrine, which acts at β1
adrenoceptors in both the electrical and muscular tissue of the atrium and ventricle. The
effect of the sympathetic nervous system is to increase the heart rate. It does this by
increasing the rate of rise of the action potential and the slope of the diastolic depolarization.
To accommodate for the decrease in filling time, sympathetic stimulation also increases the
rate of relaxation of the myocardium. Unlike the parasympathetic nervous system,
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sympathetic stimulation also increases the inotropic state of the myocardium by increasing
the amount of calcium that enters the cytoplasm of the myocardial cell. These myocardial
cell effects are somewhat slower than those following vagal stimulation, occurring over
several beats (for a review of nervous control of heart rate see Berne and Levy, 1997; Katz,
1992; Levick, 1995; Levy, 1979; Randall, 1984).
As already noted, the ultimate rate of the heart is determined by ion flux across cells
in the sinoatrial node, presumably as influenced by the autonomic nervous system. A full
elucidation of precisely which ions, and channels, is a matter of active debate in the literature
and beyond the scope of this dissertation. It should be noted, however, that there are
essentially three electrophysiologic changes that could alter rate. One, a reduction in the
level of membrane polarization so that the length of diastolic depolarization is shortened,
lessening the time required to reach depolarization. The level of membrane polarization is a
function of potassium ion movement. Secondly, the slope of the diastolic depolarization
could steepen irrespective of the level of maximum diastolic potential. The slope of this line
is regulated by sodium movement via the If current, a decrease in hyperpolarizing potassium
movement, and to some degree the entry of calcium via its specific channels. The third, and
least likely, mechanism by which heart rate could be altered is a decrease in the threshold at
which the cell depolarizes completely or fires (see Berne and Levy, 1997; Levick, 1995;
Katz, 1992; Campbell et. al., 1992).
Obviously, these ionic currents can function without the input of the autonomic
nervous system, although they are also modulated by nervous input. Interest in investigating
how the heart functions intrinsically, without input from the autonomic nervous system has
led to the development of several experimental preparations. Many early investigators
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simply cut the vagus and sympathetic nerves. This does not remove the heart from the
influence of epinephrine released by the adrenal gland with sympathetic stimulation.
Additionally, although the vagus is easily identified, it is somewhat more difficult to be
certain of complete sympathetic denervation. This problem was solved in another way by
relying on the ability to perfuse the excised heart via the aortic root. From the initial
observations of Oskar Langendorff in 1895 and 1897 the isolated perfused heart preparation
has played a critical role in developing our current understanding of cardiac physiology
(Marsh and Shattock, 1997; Doring 1990). Langendorff used these experiments to study the
cardiac function of the extirpated hearts of the pig, ox, and sheep. Langendorff’s
advancement, which allowed for the study of the heart removed from its neural and humoral
influences, first demonstrated conclusively that the heart was capable of intrinsic regulation.
Subsequent alterations in Langendorff’s original procedure have included the use of
perfusion buffers rather than defibrinated blood. Neely modified the procedure to form an
ejecting or working left heart preparation by cannulating the left atrium as the entry point of
oxygenated buffer. In this preparation the left atrium functions normally, passing buffer to
the ventricle via the mitral valve. This allows for the study of cardiac output and both atrial
and ventricular function (Neely et. al., 1967). A variety of cannulas and balloons can be
inserted into the left ventricle of the isolated heart to study contractile function. As would be
expected from the myogenic origin of heart beat, these isolated heart preparations beat
regularly without any input from neural or humoral substances, and the investigator is able to
control two other determinants of cardiac function, preload and afterload. In general, the
utilization of these preparations has focused on the study of contractility (inotropy) rather
than the study of the heart rate. Influenced by the opinions of Starling, who felt that heart rate
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was not altered by hemodynamic changes, and that heart rate itself had no effect on
contractility (Knowlton and Starling, 1912; Markwalder and Starling, 1912), the heart, more
often than not, is paced electrically at a constant rate. Isolated right atrial preparations also
beat without stimulation and have been used to study the effect of pharmacologic
interventions on heart rate but, with a few exceptions, little work has focused on a change in
heart rate intrinsic to the heart.
Jose is given credit for first coining the term intrinsic heart rate in 1966, although
others before him had performed similar experiments. His intent was to pharmacologically
duplicate the surgical isolation of the heart of animals from neural and humoral input, in
man. He reasoned that by blocking the “natural sympathetic and vagal stimuli to the heart
with propranolol and atropine given together, [he would be] able to produce a state closely
resembling cardiac isolation in the intact animal, without surgery and without major paralysis
of the systemic circulation” (Jose, 1966; Jose and Taylor, 1969). In addition to achieving his
goal of a pharmacologically isolated heart, Jose also focused on heart rate, calling the heart
rate following the administration of autonomic antagonists, the intrinsic heart rate (IHR).
Furthermore, he noted a lower IHR in patients with “cardiac disease” and felt this to be an
indicator of the severity of disease. The publication of this technique and the subsequent
findings of the author as to the effects of hypoxia (Jose and Stitt, 1969) and temperature (Jose
et. al., 1970) on the IHR rekindled interest in the regulation of HR outside of the effects of
the autonomic nervous system.
Cavero subsequently extended this technique of blockade of the autonomic nervous
system in order to mathematically examine the contributions of both the parasympathetic and
sympathetic nervous system as well as the contribution of the intrinsic heart rate and any
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interaction between the two branches (Cavero et al., 1976). The use of pharmacologic
denervation to study cardiac function, particularly with regard to IHR is now an accepted
technique in the literature (see as examples Brusting et. al., 1983; Bolter, 1994).
The body of literature utilizing these two techniques, extirpation and pharmacologic
denervation, to study intrinsic rate regulation is small but several important problems have
been addressed.
Increases in right atrial pressure
Perhaps the best known example of intrinsic rate regulation is the Bainbridge or
Anrep effect. Described in simplest terms this is an increase in heart rate that occurs as a
result of deformation of the right atrium. This can be elicited by physically stretching the
right atrium, or by increasing volume or pressure in the right atrium and thereby eliciting a
deformation of the atrium. This increase in heart rate is generally transient, but can be
sustained with a sufficiently large and constant stimulus. The observation was first made in
mammals by Stezinsky and von Bezold in 1867 but the effect exists in both vertebrate and
invertebrate hearts and has been extensively reviewed (Jensen, 1971). Bainbridge noted that
by infusing fluid and increasing the venous pressure in the anesthetized dog, a tachycardia
occurred. He further observed that sectioning the vagus nerve abolished the effect and so the
“Bainbridge reflex” was presumed to be due to vagal withdrawal in response to increasing
right atrial pressure (Bainbridge, 1915). Anrep subsequently confirmed these findings and
concurred that the tachycardia was the effect of the autonomic nervous system, and the effect
was greater if the starting heart rate was slower (Anrep and Segall, 1926). Similar results
were also shown in response to mechanical stretch applied to the right atrium (Brooks et. al.,
1966, Kappagoda et. al., 1972). The observations of several others, however, conflict with
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the notion that this is an effect of the autonomic nervous system. The effect is present
despite autonomic blockade with hexamethonium (nicotinic receptor antagonist), as well as
with atropine and propranolol, (Bolter, 1994; Jensen 1971; Vatner et. al., 1974). The
response is also observed in vitro (Brooks et. al., 1966; Blinks, 1956). These findings have
led to the conclusion that the tachycardia is not a reflex mechanism (extra- or intra-cardiac)
but is an intrinsic property of the right atrium (Brooks and Lange, 1977; Pathak, 1966). For
the purposes of this discussion it should be noted that the phenomenon is readily observed in
rats, although to a somewhat lesser degree (12.2% increase in heart rate) (Pathak, 1958) and
that distension of the left atrium does not have an effect (Jensen, 1971).
Atrial Natriuretic Peptide
A confounding factor in attempting to understand the role of changes in right atrial
pressure and its effect on intrinsic heart rate is the role of atrial natriuretic peptide (ANP, also
known as atrial natriuretic factor (ANF)). As alluded to above, one role of the atria is to act
as volume receptors, and the atria contain specialized nerves with receptor endings much like
baroreceptors to carry out this function (Gauer, et. al., 1961; Levick, 1995). The release of
ANP, however, is endocrine in nature and not dependent on neural mechanisms. The
precipitating event for ANP release is volume or pressure changes that result in distension of
the atria (Lang et. al., 1985; Ruskoaho et. al., 1986; Ledsome et. al., 1985; Metzler et. al.,
1986). The release of ANP is also induced by tachycardia (Bilder et. al., 1989; Riddervold et
al., 1991). It has been suggested that this endocrine response may differ from the stretch
response by requiring both elevated transmural pressure, as well as an increase in rate. The
combination of these effects reduces the amount of shortening of the myocyte and this is
thought to be the signal for ANP release (Cho, et. al., 1991). The distinction is germane to
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this discussion because two seemingly similar physiologic events have the opposite result
with regard to the intrinsic regulation of heart rate. The known effects of ANP include
natriuresis, diuresis and vascular smooth muscle relaxation all appropriate compensatory
responses to an acute volume overload. Another effect of ANP, unlike the effect of stretch
discussed above, is the lowering of heart rate (Atchison and Ackermann, 1990; Favaretto et.
al, 1997; Portaluppi et. al., 1990). The decrease in heart rate, in addition to alterations in the
autonomic nervous system, has a component that is intrinsic to the heart (Ackermann et. al.,
1988). This effect is not mediated directly by ANP, however, because ANP administered
directly to isolated atria or hearts does not alter heart rate (Hiwatari et.al., 1986; Atchison and
Ackermann, 1990). Therefore, by an unknown mechanism, ANP released in response to
volume overload, decreases the observed intrinsic heart rate.
Hypertension
In the spontaneously hypertensive rat (SHR) an increased heart rate observed at two
weeks of age has been demonstrated, with pharmacologic blockade, to be the result of an
intrinsic elevation in heart rate (Tucker and Johnson, 1984). These animals are known to
have increased sympathetic tone and the hypothesis was considered that an increase in
sympathetic tone alone would increase IHR. It has subsequently been demonstrated that a
long term increase in sympathetic activity or β-adrenoceptor stimulation is not sufficient to
increase the IHR (Nyalander and Dahlstrom, 1984, Machado et. al., 1987). Recently, it has
been shown that the increase in IHR in the SHR rat remains at four weeks of age and that
there are no differences in catecholamine levels between SHR and WKY rats at this time
point (Dickhout and Lee, 1998).

20

Angiotensin II, a humoral factor whose circulating levels are increase in some forms
of hypertension, administered over three hours will increase the rat heart rate by 27% despite
antagonism of the autonomic nervous system (Machado et. al., 1987). This is in agreement
with in vitro studies that have demonstrated a positive chronotropic effect of angiotensin II,
which was present even in reserpinized guinea pigs (Nakashima et. al., 1982). Although
Machado refers to this as an increase in “intrinsic” heart rate, there is no evidence to suggest
that the heart rate would remain elevated if angiotensin II were removed from the preparation
or if AII receptors were blocked. Nor has it been demonstrated that the in vitro rate of an
isolated heart or right atrium is elevated following angiotensin exposure in vivo. In a onekidney-one-clip (1K1C) model of renal hypertension an interesting observation has been
made. By seven days after surgical intervention 1K1C animals had developed an elevation in
IHR that was not present at four days. Some of these animals were also subjected to
sinoaortic deafferenation (SAD) prior to 1K1C as a means of increasing sympathetic drive.
Although animals receiving both treatments (SAD and 1K1C) had an elevated in vivo, or
basal, heart rate, the IHR was lower than control. The authors interpreted this to mean that
the increase in IHR in hypertensive rats was dependent on an intact baroreflex and that
increased sympathetic drive actually lowered IHR (Machado and Brody, 1989). One
possible explanation of their findings is that when increased sympathetic tone is combined
with the 1K1C model of hypertension there may have been less activation of the reninangiotensin system. If angiotensin II is responsible for the increase in IHR then SAD would
abolish it.
Although it appears that there is an increase in heart rate in the development of
hypertension, and that this is independent of the autonomic nervous system, it remains
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unclear if the elevation in the IHR is dependent on the continual presence of elevated levels
of angiotensin II.
Exercise
Resting bradycardia in a well trained individual is a widely recognized adaptation of
the circulatory system. Initially this was thought to be due to changes in the input of the
autonomic nervous system to the heart, a decrease in sympathetic input or an increase in
vagal tone, and possibly a decrease in the number of β-adrenoceptors. Utilizing the
pharmacologic determination of intrinsic heart rate, it was determined that an intrinsic
bradycardia was also present (Bolter et.al., 1973; Hughson et.al., 1977; Lewis et. al., 1980;
Lin and Horvath, 1972; Sutton et. al., 1967). As was observed in the example of
hypertension, the intrinsic heart rate determined in this fashion alone does not exclude the
possibility that a humoral substance, which acts via a mechanism other than the βadrenoceptor or muscarinic receptors, could be influencing heart rate. In this instance,
however, the lowering of the intrinsic heart rate following exercise training has also been
demonstrated in isolated atria and hearts, thus ruling out the possibility of a humoral
influence (Bolter and Atkinson, 1988; Nylander et. al., 1982; Schaefer et. al., 1992). Of
particular interest, those rats who have undergone a chemical sympathectomy prior to
training do not develop a lowering of their intrinsic heart rate, and β-adrenoceptor blockade
with propranolol also prevents its development (Nylander et. al., 1982; Harri and Kuusela,
1982). The concentration response relationship of isolated atria and hearts to the βadrenoceptor agonists, isoproterenol and norepinephrine, demonstrates no changes in
maximal response or sensitivity of response to agonist (Bolter and Atkinson, 1988; Schaefer
et. al., 1992). Nor is there a change in responsiveness to atropine or a combination of
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atropine and norepinephrine (Bolter and Sanders, 1988). The current data support the
hypothesis that training produces a lowering of the intrinsic heart rate via mechanisms that do
not depend upon the continual presence of a humoral substance, and furthermore, appear to
be mediated by the sympathetic nervous system.
Alterations in body temperature
Changes in body temperature can also affect the intrinsic rate of the mammalian
heart. This phenomenon was first observed by utilizing the isolated heart model (Knowlton
and Starling, 1912). The findings have been confirmed by pharmacologic method of
determination of intrinsic heart rate in rats (Walsh, 1969) and in both nonhuman primates
(Gorman and Proppe, 1984) and humans (Jose et. al., 1970). In both primate experiments, up
to 40% of the tachycardia observed was due to intrinsic changes in automaticity and there
was a consistent increase in heart rate, by approximately seven beats per minute per degree
centigrade temperature increase, to a plateau of 40 degrees. Lowering of the temperature of
the heart below normal leads to a slowing of the heart rate, a principle frequently relied upon
in cardiac surgery. Paradoxically, the long-term adaptation to heat stress includes a
bradycardia that is also mediated by changes in the intrinsic heart rate (Horowitz and Meiri,
1993).
Age
One of the first findings made utilizing pharmacologic antagonism to determine the
IHR was that this entity decreased with age in humans (Jose and Collison, 1970). This
finding has been confirmed in man (Craft and Schwartz, 1995) and observed in both dogs
and rats, including isolated rat atria and hearts (Kreider et. al., 1984; Schmidlin et. al., 1992)
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Miscellaneous
A number of other factors have been reported to have chronotropic effects that are not
dependent upon the autonomic nervous system. Male rats have been shown to have a lower
intrinsic heart rate than females (Chandler and DiCarlo, 1998). Among neuropeptides,
neuropeptide Y (NPY) and Somatostatin, Nociceptin (Giuliani et. al., 1997), and Endothelin
(Zhu et. al., 1997) have been reported to decrease heart rate, while vasoactive intestinal
peptide (VIP), calcitonin gene related peptide (CGRP) (Huttemeier et.al, 1993), Neurotensin,
and Histidine have been observed to exert positive chronotropic effects (for reviews see
Armour et.al., 1992; Corr, 1991). Recently, adrenomedullin, released from the adrenal gland
in stressful situations, has been correlated with an increased heart rate (Hirata, 1996; Nishio
et. al., 1997). Obviously, changes in ion concentration and even osmolality can have a direct
impact on heart rate. Hyperkalemia can arrest the heart and hyponatremia is associated with
an increase in the intrinsic heart rate (Bush and Vollmer, 1983).
This list is not all inclusive, and is growing with each year. For most of the agents
reported to affect heart rate the investigation of their mechanism of action is incomplete.
These findings, however, do raise fundamental questions with regard to the regulation of
heart rate. Is a change in heart rate simply reflective of an alteration in blood pressure or
some other stimulant of the autonomic nervous system, with reflex effects on heart rate? Is
heart rate adjusted outside of the autonomic nervous system? It is important to note that of
all the mechanisms discussed above that modify intrinsic heart rate, only exercise-training
and age have been found to exert a lasting modification. That is to say that while the others
may modify heart rate outside of the autonomic nervous system, they have not been proven
to modify heart rate in a fashion that outlasts their physical presence in the blood or bathing
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medium. Only exercise and age have been demonstrated, via both pharmacologic blockade
and in vitro preparations, to “reset” the intrinsic heart rate. The possibility of a prolonged
alteration, or resetting, of the intrinsic heart rate in sepsis will be the focus of the remainder
of this discussion.
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Myocardial Function in Sepsis

The cause of death in patients with septic shock has been attributed to one, or more, of
three processes. Refractory hypotension caused by peripheral vasodilatation that is
unresponsive to vasopressors, myocardial depression, or multiple organ failure (Parker et. al.,
1987). The second, myocardial depression or myocardial failure, is often a component of the
third, and has been the subject of much experimental interest. Essentially two questions
needed to be addressed to determine the nature of cardiac failure in sepsis: (1) Does the heart
fail in sepsis, and if so, when? (2) What is the nature of the myocardial failure?
Remembering that the heart functions as a pump, the answer to the second, the nature of the
myocardial failure, could have one of several origins. These include: (a) failure of preload
via a decrease in venous return; (b) a failure of afterload resulting in such profound
hypotension that the coronary arteries are not perfused; (c) a failure of inotropy via one of
several possible mechanisms, including depressive effects on normal cellular function, loss
of ionic gradients or aberrant responses to normal regulatory signals. Furthermore, a change
in any of these results in a chain of events ultimately effecting the others.
The septic process
A brief examination of the septic process and the experimental techniques used to induce
sepsis in animal models illustrates some of the difficulty previous investigators have had in
determining the answer to these questions. The reader will recall that sepsis is now defined
as SIRS as a result of proven infection. Bacteremia is the presence of bacteria in the blood,
and endotoxemia is the presence of endotoxin in the blood. It should also be recalled that
gram negative bacteria contain a lipopolysaccharide (LPS) outer wall, and that endotoxin and
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LPS are synonymous terms. Composed of lipid A, repeating oligosaccharide O antigens and
a polysaccharide core, LPS has been identified, via injecting only this component of the
bacteria, as the pathogenic mechanism of gram negative infection, and that all of the systemic
manifestations of sepsis are present following endotoxemia (Natanson et. al., 1986). It is the
lipid A portion that conveys toxicity and the O antigen represents bacteria to bacteria
variability. Generally, it is believed that LPS binds to LPS binding protein (LBP) produced
by the liver and circulated throughout the body. This complex then binds to CD 14 receptors
of immune cells, precipitating the inflammatory response including the production of
cytokines particularly tumor necrosis factor α (TNF-α), interleukin- 1 (IL-1) and interleukin6 (IL-6), although it is recognized that a host of other cytokines are also produced. (Abel,
1993; Redl et. al., 1994; Rietschel and Wagner, 1996). LPS can also stimulate endothelial
and epithelial cells by a mechanism that is not fully described. There also appears to be a
soluble CD14 receptor that binds LPS resulting in the stimulation of these cells without the
involvement of LBP (Rietschel, et. al., 1996; Ulevitch and Tobias, 1995). Endotoxin does
not seem to be directly damaging to the heart. What is more likely is that the sequelae of the
inflammatory response, particularly the cytokines precipitate the observed cardiac
dysfunction (Parker and Adams, 1979; Muller-Hocker and Haerty, 1993).
Experimental Models
Sepsis and septic shock can be induced experimentally in many ways and this has led to a
great deal of confusion in the literature. Live or dead bacteria can be injected directly into
the blood, the peritoneum or subcutaneous spaces. Endotoxin can be administered in the
same fashion by bolus injection, continuous infusion or via osmotic mini pumps. In an
attempt to better duplicate human sepsis some investigators have tried cecal ligation and
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puncture, the i.p. injection of fecal inoculum or the implantation of infected clots (Chaudry
et. al., 1993, Spitzer, 1993). A menagerie of animals has also been used including mice,
rats, guinea pigs, pigs, sheep, dogs, baboons and horses. Depending upon which method is
utilized the septic response takes a varying amount of time to develop. For instance bolus
injection of endotoxin results in a rapid drop in blood pressure which reaches its lowest point
at eight minutes. The septic response to intraperitoneal endotoxin, or cecal ligation and
puncture (CLP) takes much longer to develop. With intraperitoneal administration (LPS 5
mg/kg, i.p.) plasma endotoxin levels do not peak until two hours and remain elevated for at
least 5 hours. Intravenous injection of the same dose results in an initial peak of plasma
levels followed by a continuous gradual decrease (Bahrami et. al., 1993). Some animal
models employ large doses of intravenous endotoxin which leads to immediate hypotension
and a precipitous drop in cardiac output resulting in the death of the animal in several hours
(Chaudry et. al., 1993). Other potentially compounding factors include, whether the animals
are anesthetized or not, and which species was used. The experimental model used has
particular relevance in understanding the literature and in terms of extrapolating the results to
human disease. In most cases humans are not exposed to a single overwhelming bolus of
endotoxin, but rather a more constant slow exposure over a period of time, or intermittent
exposure such as with bacterial lyses with each antibiotic dose.
Does the heart fail in sepsis?
Experimentally addressing the two questions above as to when the heart fails, and what is
the nature of the failure, presented unique experimental challenges exacerbated by the variety
of models used. Due to the presence of normal to supranormal cardiac outputs the
recognition of whether or not the heart failed in sepsis was delayed for a considerable period
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of time. A decrease in cardiac output is not generally observed until shortly before the
demise of the host. Initially, it was felt that cardiac failure was a component only of terminal
sepsis and was referred to as “cold-shock.” At this stage the skin was cold and clammy and
there was a weak pulse. The counterpart of “cold-shock” was known as “warm-shock”, an
earlier period in sepsis when the skin was warm and there was a bounding pulse coupled with
hypotension (Waisbren, 1951; Weil and Nishijima, 1978).
As was discussed earlier, to truly examine the function of the heart as a pump the
investigator must control the influencing factors, preload, afterload, inotropy and heart rate.
Unfortunately, all of these parameters are significantly altered in sepsis. Circulating blood
volume and preload decrease as a result of “capillary leak”, afterload is profoundly altered
by pronounced vasodilatation induced in part by nitric oxide (Thiemermann 1997), and heart
rate is significantly increased except during the agonal period. Tachycardia and decreased
afterload increase cardiac output, which can obscure decreases in contractility. Decreases in
preload can make the normal heart appear dysfunctional due to a reduction in end diastolic
volume. Another important consideration is what measurements of cardiac function are used,
i.e. in vivo measurements compared to in vitro models. Cardiac output, left ventricular
change in pressure over time, left ventricular developed pressure or a host of other derived
measures have all been proposed as appropriate measures of cardiac function (Krosl and
Pretorius, 1993). One of the first groups to investigate this problem demonstrated increased
contractility following the induction of sepsis in the dog and related cardiac failure to
circulatory deficits (for review see Raymond, 1990). Goodyear, in an early study conducted
in mongrel dogs, suggested that at three hours after salmonella administration the only
cardiac dysfunction “is primarily determined by peripheral mechanisms.” He did consider
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the possibility that the hypoperfusion could cause “cumulative myocardial damage”
(Goodyear, 1967). Gilbert, in a 1960 review, stated that there was no evidence of an
alteration in the heart’s ability to perform work and therefore the effects must be vascular
(Gilbert, 1960). This thought was reinforced by Hinshaw and others when they demonstrated
no adverse cardiac effect between one and three hours after endotoxin administration
(Hinshaw et. al., 1972a).
Solis and Downing were the first to demonstrate myocardial failure before the agonal, or
terminal period following endotoxin administration (Solis and Downing, 1966) and it was
shortly thereafter confirmed in early human sepsis (Siegel et. al., 1967). Many of the early
discrepancies had to do with the length of the experimental protocol. In the same year as his
previous report, Hinshaw was able to document myocardial dysfunction three to six hours
after endotoxin (Hinshaw et. al., 1972b). Krosl demonstrated in a sublethal sheep model of
endotoxemia that decreases in contractility took four hours to appear (Krosl et. al., 1994).
Myocardial failure at some time point was now recognized as a major component of sepsis,
though the mechanism underlying this failure was unclear.
Failure of afterload and myocardial ischemia
A way in which circulatory failure could contribute to myocardial dysfunction outside of
changes in preload would be myocardial ischemia. This led to one of the first hypotheses
advanced that suggested that the myocardium failed in sepsis because of hypoperfusion and
ischemia. The reasoning was that if the heart muscle was inadequately supplied with oxygen,
due to a decrease in perfusion pressure and increased demand, the myocardium would
become globally ischemic and inotropy would suffer. Animal models generated conflicting
data. Some investigators found decreased coronary perfusion in dogs (Elkins et. al., 1973;
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Kleinman et. al., 1980). In contrast, experiments in pigs and cats showed a decrease in
coronary vascular resistance and an augmentation of coronary blood flow (Shapiro et. al.,
1985; Lefer, 1979). It has since been demonstrated in both animals and humans, that
coronary perfusion is preserved in sepsis. Furthermore, there is little lactate production and
the fractional extraction of arterial oxygen decreases, suggesting the oxygen supply is
adequate (Adams et. al., 1990; Cunnion et. al., 1986; Dhainaut et. al., 1987).
Evidence for intrinsic failure of inotropic function and its mechanism
Eventually, evidence began to accumulate that changes in the periphery were not the
proximal cause of the myocardial dysfunction. With the advent of the pulmonary artery
catheter to measure cardiac preload in humans it became recognized that the “cold shock”
was really a combination of hypovolemia and sepsis induced myocardial dysfunction
(Cunnion and Parrillo, 1989). Even if the animal or patient was fully fluid resuscitated,
however, the inotropic properties of the septic heart were not equal to control (Goldfarb,
1985, Sugi, 1991). It was now recognized that there could be some degree of inotropic
failure of the heart and measurements of its ability as a pump (CO) remain elevated, i.e.
hyperdynamic, due to the markedly decreased afterload.
Some of clearest evidence of an intrinsic decrease in the inotropic properties of the heart
came from in vitro experiments on hearts of animals exposed to endotoxin in vivo. These
experiments allow the investigator to precisely control all determinants of pump function,
preload, afterload and heart rate, leaving only inotropy as the tested variable. Parker and
Adams demonstrated a decrease in the rate of tension development in isolated atrial and
ventricular muscle strips of guinea pig following LPS administration (Adams, 1984; Parker
and Adams, 1981). Others, using the isolated rat heart after exposure to intraperitoneal LPS,
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or endotoxin administration via osmotic minipumps, confirmed a 25 – 50 % reduction in
contractile performance early in the septic insult (Fish et. al, 1985; McDonough et. al., 1984;
Romanosky et. al., 1986).
Now that it was clear there was myocardial failure in sepsis, that it occurred relatively
early in the process, and that it was related to a decrease in contractility, investigation was
directed toward determining the mechanism. A considerable amount of effort has been
directed toward identifying a humoral myocardial depressant factor (MDF). Using cultured
neonatal rat myocytes, Parillo demonstrated a decrease in the extent and velocity of myocyte
shortening when the cells were exposed to the serum of septic humans with decreased
ejection fractions. Serum of recovering patients did not have any depressant effect on the
myocytes (Parrillo et. al., 1985). A number of investigators advanced the hypothesis that
MDF had its origins in the pancreas (Lefer, 1979). Others concluded that because blood
from dogs in septic shock did not depress the myocardial function of normal dogs, and that
pancreatectomy did not prevent myocardial failure, that there was unlikely to be any MDF
(Hinshaw, 1979).
Electrolyte and fluid disturbances have also been proposed as a mechanism of myocardial
failure. Utilizing electron microscopy swelling of the myofibrillar elements and
mitochondria has been shown (Coalson et. al., 1972). Others have shown an increase in the
myocardial interstitial space and a decrease in the collagen content of rat hearts in sepsis
(Gotloib et. al., 1992; Yu et. al., 1997). Several studies have shown that there is an increase
in cellular sodium and a decrease in cellular potassium concentrations in skeletal muscle
during sepsis or endotoxemia (Chiao et. al., 1992; Karlstad and Sayeed, 1987). In agreement
with these findings, Liu’s group has correlated decreased sodium-potassium pump function
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and internalization of the sodium-potassium pump with a decrease in cardiac performance
during sepsis (Liu, 1990; Tang et. al., 1993) and Schornack showed a 25% decrease in pump
translocase activity (Schornack et. al., 1997). Archer has suggested that insulin improves
cardiac function in sepsis by increasing intracellular potassium (Archer et. al., 1978).
Conversely, increased phosphatase activity of the Na+ - K+ ATPase pump activity has been
demonstrated in skeletal muscle (Jacobs et. al., 1991) and digoxin, which inhibits the pump,
has been reported to partially reverse myocardial dysfunction in sepsis (Coalson et. al., 1972;
Narasaway et. al., 1989). No attempt has been made to reconcile these contradictory
findings. Compounding the issue, an increase in free cystolic calcium has been implicated as
the cause of cardiac failure in sepsis (Hotchkiss and Karl, 1996; Deaciuc and Spitzer, 1987)
and impaired function of the cardiac sarcoplasmic reticulum has been demonstrated four
hours after endotoxin administration to dogs (Wu and Liu, 1991). Others, however, have
shown normal function of the sarcoplasmic reticulum (Kutsky and Parker, 1990;
McDonough, 1988). A normal amount of intracellular calcium coupled to a decreased ability
of the myofilaments to respond to calcium, was shown in cardiac myocytes exposed directly
to LPS (Yasuda and Lew, 1997). Again pointing to the discrepancies regarding the model
used, guinea pigs exposed in vivo to endotoxin demonstrated decreased calcium availability
and normal myofilament response (Rigby et. al., 1998).
Over the past decade a great deal of the work examining sepsis in general, and its
attendant myocardial dysfunction in particular, has focused upon the role of nitric oxide
(NO). It is clearly recognized that there is an upregulation of inducible nitric oxide synthase
in a number of cells, including myocytes following endotoxin exposure (Johnson and Billiar,
1998; Payen et. al., 1996). Furthermore, the increased production of nitric oxide via this
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pathway is contributory, if not solely responsible for, the hypotension seen in sepsis
(Robertson et. al., 1994; Thiemermann, 1997). As discussed this hypotension could
jeopardize cardiac function if preload or afterload were severely altered. What is less clear,
however, is whether NO has any direct or indirect effects on myocardial inotropy. While
several authors have suggested that NO produces an inhibition of myocardial contraction
(Brady et. al., 1993; Finkel et. al., 1992; Hebertson et. al., 1996; Weiss et. al.,1997; Kumar
et. al., 1999) others have demonstrated either no effect of NO (Hock et.al., 1997; Meng et.
al., 1997; Keller et. al., 1995; Klabunde and Cotson, 1995; Toth and Heard, 1997; Weyrich
et. al., 1994), that TNF-α causes myocardial depression in the absence of NO (MullerWerdan, et. al., 1997) or that the inhibition of NO synthase has a detrimental effect on
contractility (Robertson et.al., 1994). It is possible that by-products of NO formation, such
as peroxynitrite could also be directly toxic to the heart. Further work is necessary to
elucidate the precise role NO plays in the myocardial contractile dysfunction of sepsis.
Summarizing, it is likely that there are myocardial depressive substances produced by
endotoxin, such as cytokines, NO, free radicals and others, which act in concert to cause
myocardial depression. Tumor necrosis factor and several interleukins are particularly likely
suspects (Kumar and Parrillo, 1993). Equally as likely, is that one of the effects of these
agents is an alteration in electrolyte homeostasis. At this time, however, it is unclear which
agents and which ions may be responsible for these effects and there is a significant amount
of contradictory information in the literature. One area of investigation into the intrinsic
failure of the contractile mechanisms that is better developed, and there is slightly more
consensus, is the cardiac response to catecholamines.
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Alterations in beta adrenoceptor signal transduction in sepsis
As discussed earlier norepinephrine released from sympathetic nerve terminals and
epinephrine released from the adrenal medulla increase the rate and force of the heart beat
acting primarily through β1 adrenoceptors (βAR). The signal transduction mechanism of the
βAR in the heart is propagated through the Gstimulatory coupling protein which, upon the
binding of ligand, becomes activated and binds and exchanges GDP for GTP. At this point
the Gβγ subunit of the G protein is cleaved. The Gs- GTP complex dissociates from the
receptor and activates adenylyl cyclase to increase cAMP production from ATP. The
activated GS-GTP is short lived due to the dephosphorylation of the GTP to GDP, which
allows GS to rebind the Gβγ subunit. Production of cAMP is regulated via adenylyl cyclase
activity, as well as, by its breakdown by phosphodiesterase. Ultimately cAMP alters the
function of the cAMP dependent protein kinases resulting in changes in ion channel function
and thereby cardiac function (Katz, 1992; Bohm, 1995).
With regard to sepsis, several early investigators have administered propranolol shortly
after i.v. endotoxin in dogs which, in most instances, quickly precipitated the animals demise.
This led to speculation that cardiac function was under, in fact dependent upon, sympathetic
control (Cann, 1972; Goodyear, 1967; Levy and Blattberg, 1967). Hinshaw witnessed no
survivors in adrenalectomized dogs administered endotoxin (Hinshaw et.al., 1964). During
the same time period, Bhagat demonstrated that there was a decreased sensitivity, as
measured by maximal tension, in guinea pig atrial muscles treated with norepinephrine after
endotoxin exposure (Bhagat et. al., 1970) and Parrat demonstrated a decrease in the left
ventricular dP/dt in response to catecholamines three hours after endotoxin in the cat (Parrat,
1973). These findings, a dependence on sympathetic stimulation and a lack of
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responsiveness, to catecholamines, would at first seem contradictory but again may reflect
differences in the time course and experimental model used. If early in the septic insult the
host responded by increasing sympathetic drive, as would be predicted, and the cardiac
response was dependent upon this to compensate, later failure of this mechanism would
appear as myocardial dysfunction.
A brief review of the terminology used to describe decreases in responsiveness to
ligands and the mechanisms of development would be useful at this point. Diminished
responses to the same concentration of a receptor to agonist over a short period of time
(minutes to hours) is referred to as desensitization or tachyphylaxis. This change in
responsiveness is a common phenomenon, particularly of the βAR, following exposure of
cells to a high concentration of agonist. Desensitization can occur via either a homologous or
heterologous mechanism. The former is hormone specific, or in other words, involves
changes in particular receptors, and consists of four possible processes. (1) The receptor may
be internalized (and therefore cannot bind drug). (2) The total receptor number may decrease
due to enzymatic degradation also referred to as down regulation. (3) The receptor may
become uncoupled from its signal transduction mechanism (in this instance the G protein).
(4) There may be a decrease in the affinity of the receptor for agonist. Heterologous
desensitization involves changes in the signal transduction pathway rather than the receptor.
Examples would be G-protein changes or alterations in adenylyl cyclase activity (Harden,
1983; Fleming, 1997; Katz, 1992; Ross, 1997). These mechanisms are heterologous in that
more than one receptor may utilize the same, or portions of the same, signal transduction
pathways and a change here would diminish responses to all agonists that use that
transduction process. In both homologous and heterologous desensitization, administration

36

of an equal amount of drug after an initial exposure results in a decreased response. It would
be insufficient if an attempt were not made to delineate between desensitization and
subsensitivity (also called tolerance). This is a distinction often lost in the literature. As
described, desensitization develops quickly and has been reported to involve changes only in
the receptor or its signal transduction cascade. The most notable distinguishing characteristic
between desensitization and subsensitivity is the time frame in which it develops.
Subsensitivity requires hours to days for development. Subsensitivity can also be specific,
i.e. to a single hormone and receptor, but is frequently nonspecific, in that the dose response
curve for any agent that elicits the experimental response is shifted to the right. (Fleming,
1997; Fleming and Westfall, 1988; Johnson and Fleming, 1989). The mechanisms producing
both desensitization and subsensitivity may be similar with two notable exceptions. Changes
in sensitivity often require a modification in the cellular abundance of specific proteins,
hence the longer time course. The other distinction is that mechanisms have been proposed
by which sensitivity is altered that do not directly relate to the receptor or its signal
transduction mechanism, e.g. changes in membrane potential (for a review of these terms see
Fleming and Taylor, 1995; Johnson and Fleming, 1989). The converse of subsensitivity is
denoted supersensitivity (dose response curve shifts to the left), there is no widely recognized
increase in responsiveness occurring over a short period of time.
Based on these descriptions and the suggestion of decreased BAR responsiveness, it
is important to answer several questions with regard to sepsis. Is there an increase in
sympathetic activity that could precipitate either desensitization or subsensitivity of the
myocardium? What is the time course of changes in responsiveness? Where in the receptor signal transduction cascade have alterations in responsiveness occurred?
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Following the administration of endotoxin there is a pronounced response of the
sympathoadrenal system. Plasma epinephrine (EPI) levels increase to over 45 times the
normal level but quickly begin to return toward control values by three hours after the septic
insult in the rat. Norepinephrine (NE) levels do not demonstrate as rapid , or as pronounced
of an increase (approximately six times normal), but remain elevated, with a gradual
diminution of the level throughout the septic course (Jones and Romano 1989, McKechnie et
al 1985). Endotoxin administered to rabbits causes an immediate increase in EPI that peaks
at 500% of normal at one hour, NE levels rise more slowly and are 300% of normal at 6
hours (Heiffer et. al., 1960). A similar relatively rapid rise in EPI and a slower smaller
increase in NE has also been demonstrated in dogs (Nykiel and Glaviano, 1961; Spink et. al.,
1966; Rosenberg et. al., 1961). Increases in plasma catecholamines are also clearly seen in
human patients. It is interesting to note that, in humans, higher catecholamine levels are
correlated with a worse prognosis (Benedict and Rose, 1992).
Coincidental to the increase in plasma catecholamines, is an increase in the
postganglionic sympathetic nerve firing rates to the heart and spleen in cats (Halinen et. al.,
1977) and to the kidney of rats (Palsson et. al., 1988). A 700% increase in the rate of NE
turnover was observed in a rat model of endotoxemia (Pardini et. al., 1983). Over time, there
is a depletion of NE from end organs in endotoxemia (Heiffer et. al., 1960;Pardini et al
1982). Depletion of norepinephrine from tissues can occur in one of several ways; decreased
synthesis, decreased reuptake into the nerve terminal, decreased vesicularization after
reuptake or increased metabolism. Decreased reuptake has been demonstrated in the spleen
but not the heart of endotoxemic rats (Pardini et al, 1982). Increased neuronal metabolism of
NE has been suggested in the rat and guinea pig after endotoxin exposure (Bhagat et. al.,

38

1979; Pardini et. al., 1982). There is also evidence from the crayfish to suggest that the
number of quanta of NE released per stimulus is increased by endotoxin (Parnas et. al.,
1971).
In addition to these alterations in NE release and reuptake, the initiating mechanism
for the sympathetic response that leads to NE release may be altered. Hypotension or other
homeostatic reflex mechanisms appear to play less of an important role and endotoxin itself,
or the inflammatory response to it, may be modulating the increase in catecholamine levels.
This statement is based on several experimental findings. Changes in autonomic activity in
endotoxemia do not necessarily correlate with alterations in blood pressure or heart rate.
Most in vivo experimental models demonstrate only a transient drop in blood pressure or no
hypotension and a slower and prolonged elevation of HR which does not correlate with BP or
catecholamine changes (Lang et al, 1985; Palsson, 1988; Jones and Romano, 1984, 1989).
Plasma catecholamine levels become elevated to many times normal even in the sinoaortic
denervated rat (Zhou et al 1991). Additionally, endotoxin has been demonstrated to cause
enhanced release of catecholamines at peripheral nerve terminals in response to constant rate
stimulation of the sympathetic nervous system in the pithed rat. The data from this study
suggested that the rise in plasma catecholamines after endotoxin administration was partially
due to a direct peripheral action of LPS on sympathetic nerve terminals, independent of
increases in firing rate (Jones et al 1994). Taken together these findings point to a significant
increase in plasma catecholamine levels in sepsis. This increase is of sufficient magnitude to
cause βAR desensitization and decreased responsiveness.
As already discussed alterations in agonist concentration can lead to changes in
receptor populations. Several investigators have reported changes in the βAR population in
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endotoxemia and sepsis. Endotoxin induced a decrease in βAR number in canine
lymphocytes by 41% when observed five hours after LPS injection (Silverman et. al., 1990).
Guinea pig lymphocyte βAR sites were reduced 38% four days after endotoxin exposure
(Van Oosterhout et. al., 1989). In a rat model, utilizing a high dose of endotoxin (30 mg/kg),
Shepherd, found there to be an approximately 12% decrease in βAR density in the heart at
three hours and observed no differences in binding affinity or between high and low affinity
sites (Shepherd et. al., 1986). In a follow up experiment the same group demonstrated a 25%
reduction in βAR density of isolated myocytes four hours after a 1 mg/kg dose of endotoxin
(Shepherd et. al., 1987). A 50-mg/kg endotoxin challenge in rats by another group resulted in
a 41% decrease in cardiac βAR density (Boillot et. al., 1997). Following cecal ligation and
puncture, rather than i.v. endotoxin, there was a 35% increase in sarcolemmal
[3H]dihydroalprenolol (DHA) binding capacity at 9 hours and a 39% decrease at 18 hours.
At this later time frame there was an increase in the light vesicle DHA binding in septic
animals, suggesting receptor internalization (Tang and Liu, 1996).
Other investigators, using lower doses of endotoxin (2 mg/kg), have not observed any
change in βAR concentration or affinity of the rat heart four hours after i.v. administration
(Gardey, et. al., 1994). In another study also utilizing rats, following a dose of 5 mg/kg there
was no change in the maximum binding or the dissociation constant of [3H]DHA at 0.5 or 3
hours after i.v. endotoxin administration. In the agonal stages of sepsis there was, however, a
decrease in the affinity of isoproterenol binding. The control binding modeled to a two-state
fit, whereas the endotoxin exposed animals modeled to one state of lower affinity (Romano
and Jones, 1986). Isolated cardiac myocytes exposed to activated splenocyte conditioned
media, which contains many of the cytokines seen in sepsis, for 72 hours showed no changes
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in βAR population. Exposure of the cardiac myocytes to 3 x 10-7 M isoproterenol for 30
minutes resulted in a 45% reduction in cell surface βAR (Chung et. al., 1990).
These data further reflect and reinforce the confusion in the sepsis literature that
results from the use of different species and models. There is, however, reasonable
consensus that higher doses of endotoxin do result in changes in the βAR population, likely
via internalization. There is also an indication of a likely change in isoproterenol binding
affinity at various time points. This is particularly important since it has been shown that
changes in the coupling status between the βAR and the G-protein will alter the binding
affinity of isoproterenol to the βAR (for review see Levitski, 1988). The presence of two
states of βAR, binding at high and low affinity, is due to the higher affinity of the receptor
for agonist when it is complexed to the Gs protein. When the Gs protein is uncoupled, or
unable to complex to the βAR, the receptor shows low affinity binding. Therefore, those
investigators who saw an increase in the low affinity binding state proposed that there was an
uncoupling of the βAR signal transduction mechanism at the level of the Gs protein. This
could then account for the decrease in responsiveness to catecholamines.
Measuring the signal transduction mechanisms downstream from the G-protein would
help determine if this uncoupling is responsible for the decreased responsiveness. One of the
earliest experiments in this area showed a decrease in cAMP production to isoproterenol
stimulation in rat ventricular slices five hours after in vivo endotoxin administration (Romano
and Jones, 1985). Obviously this observation could be secondary to decreased cAMP
formation via either alterations in the signal transduction or decreased activity of adenylyl
cyclase itself or increased degradation of cAMP. Romanosky demonstrated a 70% increase
in basal cAMP levels of the whole rat heart three hours after a 30 mg/kg i.v. dose of
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endotoxin. Exposure of these hearts to a concentration of isoproterenol that produced a
120% increase in cAMP levels in control animals produced only a 27% increase in those
treated with LPS (Romanosky et. al., 1986). In a follow-up to their earlier study, Jones and
Romano, examined cAMP formation in response to isoproterenol stimulation and found that
it was normal 0.5 and 3 hours after in vivo endotoxin administration. Cyclic AMP
production was, however, decreased at 6 hours in response to 10-7 M isoproterenol
stimulation. At none of the time points were basal levels of cAMP different between
exposed and control animals. The same authors also stimulated adenylyl cyclase with NaF
and 5’ guanylylimidodiphosphate [Gpp(NH)p]. Both of these agents stimulate cAMP
production distal to the βAR, most likely at the G-protein. When these agents were used
there was no difference in adenylyl cyclase activity at any time point. This finding bolstered
the idea that the G-protein could no longer couple to the receptor in the terminal stage of
sepsis and this idea was corroborated by others (Campbell and Forse, 1993; Jones and
Romano, 1986b). Cardiac myocytes isolated from endotoxin treated (30 mg/kg) rats three
hours after administration, also showed a 75 % reduction in isoproterenol stimulated cAMP
production. Cyclic AMP production in response to forskolin, a direct stimulator of adenylyl
cyclase was also markedly reduced. The cardiac membranes from these rats, in addition
showed decreased adenylyl cyclase activity in the presence of NaF and Gpp(NH)p (Shepherd
et. al., 1986). These effects appeared to be endotoxin dose dependent (Shepherd et. al.,
1987). Isolated rat hearts perfused directly with 25µg / ml of endotoxin in vitro were also
reported to have a decreased response to isoproterenol but not to forskolin (Bensard et. al.,
1994). When cardiac myocytes are exposed to the cytokine rich splenocyte-conditioned
media, isoproterenol stimulated cAMP production begins to decrease at 48 hours when
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compared to normal media. In this experiment the defect again appeared to be at the level of
G-protein as forskolin yielded equal results in both treatment groups (Chung et. al., 1990).
This decreased responsiveness does not appear to be βAR subtype specific as it has also been
demonstrated for the β2 adrenoceptor as measured by the relaxation of pig coronary
arterioles (Wang et. al., 1994). Furthermore, these experimental observations extend to
humans. Lymphocytes, which also have βARs, isolated from septic patients produce a
diminished amount of cAMP in response to isoproterenol and NaF exposure (Silverman et.
al., 1990). Although there are some differences with regard to basal cAMP levels and
response to forskolin stimulation all of these experiments have identified some degree of
hyporesponsiveness to β-adrenoceptor stimulation. The hyporesponsiveness appears to be
related to the dose of endotoxin administered and points to dysfunction at least at the level of
the G-protein if not also at the level of adenylyl cyclase. The time course of these changes,
minutes to hours, conforms to the definition of desensitization.
Evidence for a difference in the chronotropic response
Curiously, two groups of researchers have reported supersensitivity of adenylyl
cyclase activity in sepsis. Carli’s group showed an increase in cAMP production with
exposure to isoproterenol, NaF and Gpp(NH)p four hours after administering 2 mg/kg to the
rat. It is perplexing that they were unable to demonstrate this response, and in fact saw the
reverse with 1 and 3 mg/kg (Gardey et al, 1990). The authors of this report do not state
which portion of the rat heart was used for their preparation. McDonough’s group, however,
clearly demonstrates supersensitivity only in the right atrium. Their model was to examine
the heart rate response of the isolated rat heart to isoproterenol 24 hours after cecal ligation
and puncture. The authors first demonstrated intrinsic myocardial contractile dysfunction as
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would be expected. Intriguingly, they also found a 58 fold increase in the sensitivity to
isoproterenol exposure as measured by the agonist induced change in the beating rate of
isolated right atria (Smith et. al., 1986). This finding was confirmed in a repeat experiment
again using cecal ligation and puncture (Barker et. al., 1990). In this latter study, sensitivity
to forskolin was also examined and found to not be increased. It should be noted that the
same group, using the same model, also examined the sensitivity of the inotropic response in
a Langendorff perfused left ventricle model and witnessed no changes in isoproterenol
sensitivity (Smith and McDonough, 1988).
Although these findings could be dismissed as spurious, there are several distinctions
which make them stand out. The McDonough group was the only group to examine the
chronotropic response specifically. Nor have any other investigators examined the response
of the right atria in particular. These experiments were also conducted using cecal ligation
and puncture with tissue isolation at 24 hours. This model generally leads to the
development of sepsis over several hours rather than several seconds as with the i.v. injection
of high doses of endotoxin. The literature bears out why these may be important distinctions.
First, regardless of the animal model or method of inducing sepsis tachycardia is a ubiquitous
finding. Even in those studies cited above which demonstrated β-adrenergic dysfunction
tachycardia was observed. This leads to an interesting paradox because the same βadrenoceptors which mediate inotropy also mediate chronotropy. If the decreased
responsiveness with regard to inotropy is related to the receptor why is there an augmentation
of chronotropy? There is also evidence in the literature to suggest that the right atrium may
be qualitatively different with regard to β-adrenoceptor signal transduction when compared
to the ventricle and even the left atrium. The laboratory of Fleming and Taylor has shown
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differences in the development of supersensitivity between the right and left atria as well as
the ventricle of the guinea pig in response to chronic reserpine treatment (Fleming, 1984;
Fleming and Taylor, 1991; Roberts et. al., 1992). Recently, in a study also using rat cecal
ligation and puncture, a significant increase in type II protein kinase A (PKA, also called
cAMP dependent protein kinase) was observed in the right atrium that was not present in
either the left atrium or ventricle (Hsu et. al., 1997). These findings raise the possibility that
the β-adrenergic receptor signal transduction responsible for the chronotropic response to
sepsis could be modulated differently than the inotropic response at the cellular level.
A close review of this literature reveals another interesting possibility, particularly in
light of the previous discussion of the regulation of heart rate. The data of several authors
provide evidence that the tachycardia of sepsis may, in part, be due to an increase in the
intrinsic heart rate. In addition to observing supersensitivity of the chronotropic response to
isoproterenol McDonough’s group also observed an approximately 16% increase in the heart
rate of isolated hearts and isolated right atrium (Smith et. al., 1986; Barker et. al., 1990;
Muniz and McDonough 1991). Using osmotic minipumps, Fish observed a 29% increase in
the in vitro heart rate of LPS treated rats at six hours (Fish, 1985). Romanosky also reported
a 15% increase in the in vitro heart rate but in his model this was not statistically significant.
Circumstantially related to a possible increase in the intrinsic heart rate, is the observation
that heart rate remains elevated after the normalization of blood pressure, and continues to
increase even after catecholamine levels taper off (Lang et. al., 1985; Qi et. al., 1991;
Sharma et. al., 1996). In humans the heart rate has been shown to be elevated 10 days into
the septic process despite the normalization of blood pressure (Shoemaker et. al., 1993). All
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of this is suggestive that the elevation of heart rate may be intrinsic to the heart, rather than
part of ongoing autonomic regulatory mechanism.
Additional evidence for alterations in the control of heart rate in sepsis have come
from a relatively new area in the study of autonomic function. The interval between beats of
the heart (the R-R interval on an electrocardiogram) is not constant but is subject to small
fluctuations. These fluctuations are felt to be due to changes in the autonomic input to the
sinoatrial node. Heart rate variability (HRV) is then defined as the cyclic fluctuations in the
heart period over time. The measurement of heart rate variability has been proposed, and
extensively studied, as a quantitative measurement of autonomic nervous system activity (for
review of this technique see Akselrod et. al., 1981; Kuwahara et. al., 1994; Malliani et. al.,
1991; Ori et. al., 1992). Applying this technique to septic and endotoxemic humans and
rabbits three separate groups of investigators have demonstrated a decrease in heart rate
variability in sepsis. This is particularly interesting in that all three groups identify a
decrease in the sympathetic modulation of heart rate despite the presence of a significant
tachycardia (Garrard et. al., 1993; Godin et. al., 1996; Goldstein 1995). Taken together these
data suggest the following hypothesis; that the tachycardia of endotoxemia in sepsis may, at
least in part, be due to an elevation of the intrinsic heart rate. Before exploring this
hypothesis experimentally it would be appropriate to address the potential physiologic or
pathologic effects on an intrinsic elevation of heart rate in the septic myocardium.
Physiological importance
Where as Frank and Starling’s observation of the relation between length and tension
is widely recognized, an earlier description of the relationship between force and frequency is
less well known. At the end of the 19th century, Bowditch first described (Bowditch, 1871)
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what perhaps most appropriately should be called the force –interval relationship. The
Bowditch effect, also known as the treppe effect or positive staircase, states that at any
particular frequency of stimulation the heart develops a certain amount of tension. With an
increase in the frequency of stimulation the tension which the heart generates rises with each
successive beat until a new higher steady state is reached. This small stepwise increase in
tension displayed graphically appears like a staircase hence its name. It is now known that
this phenomenon is related to an increase in calcium entry into the cell. Decreasing the
interval between stimulation results in increases in intracellular calcium concentration via
both sarcolemmal calcium channels and release from the sarcoplamsic reticulum (for a
comprehensive review of the Bowditch effect see Koch-Weser and Blinks, 1963; Noble and
Seed, 1992). It is important to note that Bowditch recognized an optimal rate of stimulation
above which contraction declined. Woodworth confirmed Bowditch’s frog heart
observations in the dog heart (Woodworth, 1902). These findings and the many that
followed relied heavily on isolated tissue allowing for a focus upon inotropy. Unlike isolated
muscle, the effects of increasing rate in vivo are modest at best (Seed, 1992). This is
because, in general, the cardiac output of the heart remains constant. So as heart rate
increases there is also a decrease in diastolic filling or preload which negates any frequency
induced increase in inotropy (Levick, 1995; Ross et. al., 1965). This should not be confused
with an increase in heart rate produced by sympathetic stimulation, such as with exercise.
With catecholamine induced increases in chronotropy, stimulation of the βAR in the
ventricle results in an increase in the rate of relaxation that preserves diastolic filling and
therefore preload. There is also augmentation of the contractile process so that with
sympathetic stimulation both heart rate and stroke volume increase. The heart as a pump is
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therefore dependent upon the coordinated adjustment of several aspects of its function in
order to increase cardiac output.
Even in isolated tissues a reversal of the Bowditch effect is seen in pathological
conditions.

In human heart failure an alteration of the interval-force relationship has been

shown to occur. Isolated ventricular strips from failing myocardium at the time of transplant
show a peak function at 81 beats per minute compared to 174 beats per minute in control
hearts (Feldman et. al., 1988; Mulieri et. al., 1992). The negative impact of heart rate on
contractility is particularly acute in dilated cardiomyopathy (Schmidt et. al., 1995; Just,
1996) which is precisely the state of the failing human heart in sepsis (Parillo, 1990). From
these data the conclusion can be drawn that increases in heart rate could certainly jeopardize
the cardiac pump in sepsis. This statement would be particularly true if the βAR signal
transduction in the ventricle is dysfunctional preventing a coordinated autonomic response,
or if the mechanisms of handling cellular calcium turnover are deranged resulting in the over
accumulation of intracellular calcium which is documented to jeopardize cell function .
Increasing the heart rate also increases myocardial oxygen demands. The heart,
which in the normal state extracts 72% of the arterial oxygen delivered, has little reserve in
terms of oxygen delivery (Schlant and Sonnenblick, 1994; Vatner and Braunwald, 1972). At
least 15% of critically ill patients have been shown to develop myocardial ischemia which is
correlated with a significantly worse prognosis (Guest et. al., 1995).
As one can now see, the origin and regulation of the heart beat has been the object of
long-standing curiosity. While the heart rate is myogenic in origin it is clearly regulated by
autonomic influences. There is ample evidence, however, to suggest the possibility of
alterations in the intrinsic heart rate. Sepsis has been shown to negatively effect myocardial
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contractility while simultaneously increasing heart rate. There are also proven abnormalities
of the autonomic nervous system and its signal transduction mechanisms in sepsis. These
two processes combined result in a divergence of alterations in inotropy and chronotropy that
could exacerbate myocardial dysfunction.
These points raise several questions which the following research seeks to explore:
(1) Is there an elevation of the intrinsic heart rate in sepsis? (2) How is the tachycardia of
sepsis initiated and maintained? (3) Is there a distinction between the regulation of inotropy
and chronotropy in sepsis?
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EXPERIMENTAL DESIGN
Characterization of the septic model
As addressed in the introduction, there is little standardization of the experimental
models described in the literature to examine the effects of sepsis and endotoxin. The model
used in these experiments, a single dose (5 mg/kg) of Escherichia Coli (E. Coli) endotoxin
16-20 hours prior to the examination of cardiac function is relatively unique. The
experimental model used for these experiments was a rat model of endotoxemia. Male
Sprague-Dawley rats were used exclusively. E. Coli endotoxin (5 mg/kg) in a 2.5-mg/ml
solution of 0.9% normal saline was injected intraperitoneally at four p.m. the evening before
experimental observations. Data were collected between eight a.m. and 12 noon the
following day hence the 16-20 hour model of endotoxemia. Control animals received an
equal volume of 0.9% normal saline. Due to the unique nature of the model and the
relatively distant time point, after a single endotoxin exposure, at which cardiac function was
examined it was necessary to chronicle the vascular response in this model. Animals were
implanted with cannulae in the femoral artery. Following an overnight recovery period,
these animals were administered intraperitoneal endotoxin (5 mg/kg) and their cardiovascular
response (heart rate and blood pressure) was followed for 24 hours.
Intrinsic Heart Rate
The first hypothesis tested experimentally was that there is an elevation of the
intrinsic heart rate in sepsis, or more appropriately, endotoxemia. As discussed in the
introduction, intrinsic heart rate can be determined in one of two fashions. The first is
according to the method of Jose and extended by Cavero (Jose, 1966; Cavero et. al., 1976).
This entails injecting the animal, or patient, with a sufficient dose of atropine to antagonize
the muscarinic receptors of the heart. This is followed by the injection of sufficient dose of
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propranolol, or another beta blocker, to antagonize the βAR. This sequence is reversed in
half of the group of animals to avoid an effect of order of administration. After the animals
have received both drugs the recorded heart rate is devoid of parasympathetic or sympathetic
influences and is recognized as the intrinsic heart rate (see Experimental Methods for a
complete description of this procedure). As confirmation of the accuracy of this procedure
hexamethonium, which antagonizes the nicotinic receptors of both the parasympathetic and
sympathetic ganglia, should also pharmacologically denervate the heart. Animals treated
with endotoxin or saline vehicle in the same fashion, were then exposed to hexamethonium
and the heart rate was determined. The sequence of the intrinsic heart rate experiments is
outlined below (figure 1)

Determination of Intrinsic Heart Rate
E. Coli LPS Endotoxin
5 mg/kg i.p.

LPS

CONTROL
Anesthesia

16 - 20 hours post LPS

HRN

Record HR
Propranolol 8 mg/kg i.v.

HRA = HRo
HRP = HRo

S
V

Atropine 1 mg/kg i.v.

Record HR
Atropine 1 mg/kg i.v.

HRAP = HRo

Propranolol 8 mg/kg i.v.

Record HR

Figure 1. Experimental design to determine intrinsic heart rate. Animals had been treated
16 to 20 hours earlier with LPS (5 mg/kg). Sodium pentobarbital anesthetic (50 mg/kg) was
used. Equal numbers of LPS and Control animals received propranolol or atropine first
followed by the second drug. HRN = initial HR, HRA =HR after atropine, HRP = HR after
propranolol, S = sympathetic influence, V = parasympathetic influence, HR o = intrinsic
heart rate.
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In vitro heart rate
Neither of these experiments, however, remove the heart from influences not related
to the muscarinic or βAR that could potentially effect heart rate. The excised or extirpated
heart perfused with oxygenated buffer is removed from both neural and humoral influences.
The beating rate of this preparation is also indicative of the intrinsic heart rate. Experiments
were conducted carrying out the same endotoxin injection procedure as outlined above. At
16-20 hours the hearts were removed from the animal and perfused with oxygenated buffer
as a working left heart preparation. After a 20 minute stabilization procedure the in vitro
heart rate was recorded and followed over the next 40 minutes.
In order to exclude the possibility of spontaneous, or unstimulated, release of
catecholamines from the isolated heart, some of the hearts were exposed to propranolol after
the completion of the stabilization period. A range of concentrations was used. Since
propranolol is recognized to have membrane stabilizing properties at relatively low
concentrations (Doggrell, 1990) an experiment was therefore conducted to determine the
degree to which this property was effecting the observed results. The active, in terms of βadrenoceptor antagonism, isomer of propranolol is the levorotatory, or S (-) form. The
dextrorotatory or R (+) form is unable to antagonize the receptor but has the same membrane
stabilizing properties at similar concentrations. The isolated hearts from separate groups of
endotoxin treated and untreated animals were exposed to either the inactive R (+) isomer or
the racemic RS mixture. This allowed for the determination of the concentration at which
nonspecific, or membrane stabilizing, effects of propranolol were being observed. To rule
out the possibility of an α-adrenoceptor mediated effect some of the isolated hearts were also
exposed to the non specific α-adrenoceptor antagonist phentolamine.
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Mechanism of induction of the increased intrinsic heart rate
Catecholamine stimulation of the βAR, and concomitant parasympathetic withdrawal,
is the only widely recognized mechanism by which an organism increases its heart rate. As
outlined in the introduction there is a significant increase in catecholamine release in sepsis.
In order to determine if this catecholamine release participated in the increased intrinsic heart
rate, or if it occurred by a wholly other process, the following experiments were conducted.
Following the release of norepinephrine from a nerve terminal and its stimulation of
adrenoceptors any catecholamine that remains in the synapse is quickly taken up by a
reuptake transporter. Following reuptake, the catecholamine is then repackaged into vesicles
by a second mechanism. When this vesicular reuptake process is inhibited by reserpine, the
norepinephrine is acted upon by monoamine oxidase and catecholamines are depleted by
virtue of metabolism to inactive compounds (figure 2).
Figure 2. Effects of reserpine and propranolol at the sympathetic nerve terminal are
depicted. With stimulation of the nerve norepinephrine (NE) is released and crosses the
synapse to stimulate the beta-adrenoceptor (βR). This is antagonized by propranolol. NE is
actively taken up into the nerve and is repackaged into vesicles. Reserpine blocks the
vesicular packaging. NE not in vesicles is broken down by monoamine oxidase (MAO).
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Exploiting this drug action to deplete synaptic catecholamines, animals were pretreated with
reserpine and then exposed to endotoxin. The experimental design is demonstrated below
(figure 3).

Experimental Design:
Reserpine Pretreatment
male Sprague-Dawley rats
day 1
a.m.

reserpine 1 mg/kg

sham vehicle

day 2
a.m.

reserpine 1 mg/kg

sham vehicle

E. coli endotoxin 5 mg/kg
(LPS)

normal saline
(NS)

p.m.

day 3
a.m.

record in vivo HR, extirpate heart, perfuse as
working heart preparation, take in vitro
measurements

Figure 3. Design of reserpine experiments. Equal numbers of animals were pretreated with
reserpine (1 mg/kg, i.p.) or sham vehicle at 9 a.m. on day one and day two. At four p.m. on
day two LPS (5 mg/kg, i.p.) or normal saline (NS) was given. On day three data were
collected in the a.m., 16-20 hours after LPS.
The reserpine experiment indicated that catecholamines did play a role in the intrinsic
elevation of heart rate. This experiment did not rule out the possibility that reserpine affected
another neurotransmitter besides the catecholamines or that reserpine had a toxic effect on
the heart. It is also possible, although unlikely, that the catecholamines, which were depleted
by reserpine, were increasing the heart rate via a mechanism other than activation of the βadrenoceptor. Therefore, experiments were designed to evaluate the role of the βadrenoceptor in the elevation of intrinsic heart rate. Bromoacetyl alprenolol menthane
(BAAM) is an alkalinizing irreversible βAR antagonist. The appropriate dose and duration
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of action of BAAM were first characterized by construction of dose response curves to
isoproterenol in vivo. Once the appropriate dose antagonist had been determined the animals
were pretreated with BAAM or vehicle. Thirty minutes later equal numbers of animals
receiving BAAM or vehicle were exposed to endotoxin or saline. Sixteen to 20 hours later
the animals were sacrificed, hearts extirpated and in vitro HR recorded. Dose response
curves to isoproterenol were then performed in vitro.
An additional experiment was conducted in an attempt to answer the following
question. Was the presence of LPS (or the cytokines it stimulates) required simultaneously
with catecholamines to induce a change in IHR? The alternative hypothesis was that LPS
induced the change in IHR but the change became manifest only after exposure to
catecholamines. Presumably if the latter hypothesis were true, that catecholamines are
required only for the change in IHR to become apparent, but not to induce the change, the
HR of an isolated heart of an LPS treated animal exposed in vitro to a βAR agonist would
remain elevated even if the animal had been pretreated with reserpine. In order to examine
the chronotropic response of atrial tissue to the β1-adrenoceptor agonist isoproterenol and the
decay of this response from its maximum it was most efficient to use a preparation that
required smaller volumes of buffer. For this reason an isolated right atrial preparation was
utilized. Animals were pretreated with reserpine or sham vehicle as described above. Equal
numbers of each group were then exposed to endotoxin and sacrificed 16-20 hours later for a
total of four treatment groups. The right atria was excised and suspended via a strain gauge
recorder in a 10ml water bath. A 40-minute stabilization period was observed then a
cumulative concentration response curve to isoproterenol was constructed. Following the
final dose of isoproterenol the bath was thoroughly rinsed with fresh buffer and was rerinsed
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every 15 minutes. The HR was recorded every 5 minutes for one hour to observe the decay
in maximal isoproterenol response.
Time Course of Changes in the Catalytic Subunit of Protein Kinase A and Phosphorylated
CREB
Prolonged activation of cAMP has been demonstrated to decrease the levels of the
catalytic subunit of PKA is some cell types (Garrel et. al., 1995; Boundy et. al., 1998).
Additionally, levels of PKA activity have been demonstrated to be variable in a rat model of
sepsis depending upon the location in the heart and the duration of the septic process (Hsu et.
al., 1997). CREB is a target of PKA-C phosphorylation in the nucleus (Cooper, 1997). In
order to better characterize the time course of possible changes in PKA catalytic subunit and
phosphorylated CREB levels in our septic model, the right atria were removed from LPS
treated rats or control animals at two, four, eight and 16 hours after the onset of sepsis. The
atria were then processed for western blotting. Western blots were performed and analyzed
via densitometry using an antibody specific for the catalytic subunit of PKA and
phosphorlyated CREB.
Time Course of Changes in Heart Rate Variability
The beat to beat interval, or instantaneous heart rate, is not absolutely constant but
varies as a result of many factors including respiration, blood pressure regulation, actions of
the renin-angiotensin and other known and unknown factors. The study of this variability
can be approached in two manners: analysis in the time domain or frequency domain (Malik,
1996; Stein et. al., 1993). Analysis of the time domain examines simple statistical variability
in the heart rate and provides information as to the total variability present over a certain
period of time. Frequency domain analysis is also known as power spectral analysis. This
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method uses Fourier analysis to separate the total heart rate variability into the variability
resulting from periodic oscillations at various frequencies. The resulting spectra have been
demonstrated to provide information as to the amount of sympathetic and parasympathetic
input to total heart rate variability (Ori et. al., 1992). These findings have been confirmed in
the human and a number of experimental animals including the rat (Kuwahara et. al., 1994;
Japundzic et. al., 1990). Alterations in heart rate variability have been observed in septic
experimental animals as well as humans. Furthermore, these changes in heart rate variability
have suggested both a worse prognosis and tachycardia in the presence of decreased
sympathetic activity (Garrard et. al., 1993; Godin et. al., 1996; Goldstein 1995). In attempt
to correlate our observations of an elevated intrinsic heart rate with changes in heart rate
variability we utilized this technique in our experimental model. A total of ten rats were
anesthetized and subcutaneous electrodes were attached to either side of the anterior chest
wall. Following a 24 hour recovery period the lead I ECG tracing was monitored for 24
hours. After this control period each of the animals received 5 mg/kg of LPS i.p. and the
ECG tracing was monitored for a further 24 hours. Heart rate variability in both the time and
frequency domain was examined off line for a 5 minute time period of each hour.
Effect of Frequency on Myocardial Contractile Performance
Several additional questions arose about the experimental model. The first was
whether, in this model, there were alterations in myocardial inotropy at 4 hours after
endotoxin exposure, as many others had reported. It was also of interest to determine
whether there was a decrease in inotropy 16 hours following LPS administration, the time at
which the chronotropic changes were observed study. Additionally, it was desirable to
examine the degree to which an increase in heart rate may impact contractile indices. The
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following experiment was designed to answer all of these questions. Animals were treated
with endotoxin or saline as above. Equal numbers of animals in each group were then
sacrificed at 4 or 16-20 hours after endotoxin or saline treatment. The hearts were extirpated
and perfused as working left heart preparations. After a 20 minute stabilization period the in
vitro heart rate was recorded as before. The hearts were then electrically paced at 300, 350,
400 and 450 beats per minute. These rates were chosen as they cover the range of
physiologic heart rates observed in the rat. At each HR, cardiac output and stroke volume
and change in aortic pressure over change in time (A dP/dt) were recorded. The preparation
was then converted to a Langendorff perfusion method in order study isovolemic contraction
(see methods). At the same heart rates, the maximum change in left ventricular pressure over
the change in time (LV dP/dt max) and the left ventricular developed pressure (LVDP) for a
given preload were examined. This experiment is depicted graphically below (figure 4).

Frequency - Force Relationship
Following LPS: Experimental Design
32 male Sprague - Dawley rats

E. coli LPS

5 mg/kg i.p.

4 hours

16 hours

Normal Saline

record in vivo HR,
extirpate heart, record
in vitro HR and contractile
parameters of heart paced
at 300, 350, 400, and
450 bpm

Figure 4. Diagram depicting the experimental model used to determine the effect of
frequency of myocardial contractile performance after endotoxin administration at both 4
and 16 hours. Equal numbers of rats received either endotoxin (LPS) or saline in vivo.
Equal numbers of rats from both groups were sacrificed at 4 or 16 hours to examine heart
rate (HR) and contractile indices.
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EXPERIMENTAL METHODS
Animals
Male Sprague-Dawley rats weighing between 325 and 475 grams were used in the
following experiments. All animals were obtained from Hilltop Lab Animals (Scottsdale,
PA). Rats were housed and cared for by the West Virginia University Office of Laboratory
Animal Resources in accordance with the West Virginia University Animal Care Guidelines
and Protocol Statement in compliance with the Animal Welfare Act. Animals were
quarantined for 5 days after receipt and the Institutional Animal Care and Use Committee
approved all procedures.
Drugs
Initially sodium pentobarbital (Nembutal Sodium Solution, 50 mg/ml, Abbott
Laboratories; North Chicago, IL) was used for anesthesia at a dose of 50 mg/kg
intraperitoneally. At the request of the West Virginia University Animal Care and Use
Committee, Telazol (Fort Dodge Animal Health; Fort Dodge, IA) was subsequently used for
anesthesia. This drug consists of equal parts of tiletamine hydrochloride a dissociative
anesthetic, and zolezepam hydrochloride a nonphenothiazine diazepinone, and was used at a
dose of 30 mg/kg. Escherichia Coli (serotype O55:B5; Sigma; St. Louis, MO) endotoxin
(LPS) was prepared in normal saline at a concentration of 2.5 mg/ml and frozen in 1 ml
aliquots until use. DL-Propranolol Hydrochloride (Sigma) was brought into a solution of 1
mg/ml with sterile water, 1 ml aliquots were placed in eppendorf tubes and frozen until use.
R-(+) Propranolol Hydrochloride (Sigma) was prepared in the same fashion. Atropine
Sulfate (American Reagent Laboratories, Inc.; Shirley, NY) was purchased in 1 mg/ml vials.
Phentolamine Hydrochloride and Hexamethonium (Sigma) were prepared on the day of
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use as 1 mg/ml and 40 mg/ml solutions respectively. Isoproterenol (Sigma) was also
prepared fresh each day in various concentrations and was shielded from light until used.
Reserpine (Sigma; Louis, MO) was compounded (2.5 mg/ml) with benzyl alcohol, citric
acid, Tween 80 and water (Leyden et. al., 1956). This solution was then diluted with sterile
water to 1 mg/ml for intraperitoneal injection. Bromoacetyl Alprenolol Menthane
(BAAM) was purchased from Research Biochemicals International (Natick, MA) and was
brought into solution with 95% ethanol and then diluted with 0.9% normal saline to a final
concentration of 40 mg/kg. Normal Saline (Bacteriostatic 0.9% Sodium Chloride; Abbott
Laboratories; North Chicago, IL) was purchased in 30 ml vials. Heparin Sodium Injection
(1000 IU/ml; Elkins-Sinn, Inc; Cherry Hill, NJ) was purchased in 10 ml vials.
Buffer
Krebs-Henseleit (KH) buffer was prepared daily in 2 liter volumetric flasks. Double
distilled, nanopure water was used to bring the salts into solution. The final concentration of
the reagents, as final concentrations of the salts, was as follows: NaCl, 118 mM; NaHCO3,
25 mM; MgSO4, 1.21 mM; Dextrose 10.98 mM; KCl, 4.69 mM and KH 2PO4, 1.18 mM. The
solution was bubbled and stirred for 20 minutes. At this time calcium chloride was added for
a final concentration of CaCl2 • H2O, 2.51 mM.
In vivo cardiovascular preparation
Strict sterile technique was observed for all procedures in which the animal
recovered. After adequate anesthesia was obtained with Telazol the animals were shaved in
the groin and nape of the neck. The animals was then placed supine on a styrofoam cooler
lid which had been cleaned with alcohol and draped in a sterile fashion. Rubber bands were
placed around each foot and the rubber bands were pinned to the styrofoam to obtain access
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to the groin. The groin was then scrubbed with betadine. A small incision was made in the
left groin. Careful dissection was carried out until the femoral vein and artery had been
individually isolated. Using 3-0 silk suture proximal and distal control was obtained of each
vessel. Catheters had been prepared from 0.010 in. internal diameter X 0.030 in. external
diameter Tygon Micro-Bore Tubing, Formulation S-54-HL, Norton Performance Plastics
(VWR Scientific Products, So. Plainfield, NJ) approximately 18 inches in length that had
been individually sterilized by gas sterilization with ethylene oxide. Each catheter had two
“dumbbells”. These dumbbells were short pieces of PE-60 tubing that had been heat flared at
each end and placed onto the catheter. A small venotomy was made and the catheter was
placed, by estimation of the appropriate length, just into the vena cava. Placement and
patency was confirmed by aspirating blood and flushing easily with saline and the catheter
was clamped with a hemostat covered with plastic tubing so as not to crimp the catheter. The
suture used for distal control was then tied gently around the vein and catheter. The suture
used for proximal control was tied around a dumbbell immediately distal to the venotomy. In
the same fashion an arteriotomy was performed and a catheter inserted. The catheter was
placed in the abdominal aorta below the renal artery. Correct placement of the arterial
catheter was confirmed by the pulsatile flow of blood through the catheter. If the flow was
nonpulsatile the catheter was repositioned. This catheter was tied in place in the same
fashion as the venous catheter. The groin incision was then closed with a running vicryl
suture with only a small portion of the wound left open. The legs were freed. A hollow steel
rod with a beveled sharp end was tunneled subcutaneously from the groin to the nape of the
neck where it was brought through the skin. The internal diameter of this “tunneler” was
such that a catheter could just pass through. Individually, each catheter was advanced to the
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nape of the neck, the tunneler was removed and the catheters pulled taught. The purpose of
the second dumbbell is to create a gentle turn when the catheter is pulled from the groin to
the neck. The remainder of the groin wound was then closed. An ultraseude vest was then
fitted to the animal. The vests contain a metal hub located over the nape of the neck. The
catheters were placed through the hub and then through a spring approximately one foot in
length. In this way, the animal could not access the catheter. A 25 gauge hypodermic needle
was scored and the sharp end broken off. This needle was then placed into the end of the
catheter. Each catheter held approximately 0.1 ml of volume. The catheters were flushed
with 0.1 ml of heparin 1000 IU/ml and capped. The animals were then placed in individual
Plexiglas and stainless steel footshock chambers (model 80000, Lafayette Instrument Co.,
Lafayette, Ind.) modified to provide food and water ad libitum. The spring and catheter
exited through the top of the cage so that animals could be hemodynamically monitored and
receive injections without being disturbed (Johnson and Kotchen, 1990). After a 24 hour
recovery period the catheters were aspirated and then flushed with heparin diluted to 100
IU/ml, approximately 0.3 ml was used. The catheters were then attached to PE tubing that
had been primed with the same dilute heparin solution. In line at the site of attachment of the
catheter to the PE tubing was a small animal cannula swivel (375 Series-Single Channel;
Instech Laboratories, Plymouth Meeting, PA) that allowed the catheter coming from the
animal to rotate freely. The catheter was attached to a Novatrans II pressure transducer
(Medex Inc, Hillard, OH). This transducer was then connected through an ETH 400 bridge
amplifier (CB Sciences; Dover, HH), and then to a MacLab 8s (ADInstruments; Milford,
MA) digital recording system. Data were collected digitally at one kilosecond intervals on a
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MacIntosh LC 550 (Apple Computer; Cuppertino, CA). Blood pressure and HR were
determined from the digital tracings using Chart software (ADInstruments; Milford, MA).
Intrinsic heart rate
Determination of the intrinsic heart rate (IHR) was according to the method of Jose as
extended by Cavero (Jose, 1966; Cavero, et. al., 1976) and the design of this experiment is
shown in the preceding section. These animals were pretreated with LPS or saline 16-20
hours prior to determination of IHR. Animals were then anesthetized with Nembutal and
electrodes attached to their right arm, right leg and left leg. The femoral vein was cannulated
in the manner above. The starting HR was recorded as HRN. Propranolol (8 mg/kg) and
atropine (1 mg/kg) were administered intravenously as described in the experimental design.
The heart rate 10 minutes after propranolol is the HRP and the heart rate 10 minutes after
atropine is the HRA. The heart rate following both atropine and propranolol equals the
HRAP, or HRo, which is the IHR. Cavero described this model using the following
calculations:
HRA = HRo · S
HRP = HRo · V
HRAP = HRo
HRN = HRo · S · V · W
Where S = sympathetic contribution to HRN, V = parasympathetic contribution to HRN and
W equals the interaction, if any between the parasympathetic and sympathetic influences.
In those experiments where hexamethonium was used it was administered in the same
fashion as atropine and propranolol.
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In vitro cardiovascular preparation
For the isolated working left heart preparation (figure 5) the animals were
anesthetized with either Nembutal or Telazol as described above. The abdomen was then
opened and a bilateral thoracotomy quickly performed. With gentle lifting of the heart the
great vessels were cut with scissors and the heart immediately placed into ice-cold buffer
where it arrested. The Langendorff apparatus had at this point been warmed to 37.5° C via
jacketed glassware. With the buffer running the aortic root was mounted on the aortic
cannula well above the aortic valve and tied in place. The heart was perfused with warm
physiological salt solution via the Langendorff column at 85 cm H2O pressure and began to
beat. The total ischemic period was less than one minute. The insertion point for one of the
pulmonary veins was identified in the left atrium. The atrial cannula was inserted into this
opening and tied with a ligature around the atrium and cannula. Care was taken to not
incorporate the right atrium. The pulmonary artery was incised to insure decompression of
the right ventricle. At this point the apparatus was converted to a working left heart
preparation by closing the Langendorff column and opening the atrial reservoir. The preload
on the heart was set at 15 cm H2O by adjusting the height of the atrial reservoir above the left
atrium, the afterload was set at 70 cm H2O by adjusting the height of the aortic outflow
tubing. The buffer was continually oxygenated with a mixture of 95% oxygen and 5%
carbon dioxide and recirculated. A filter prevented the recirculation of anything large
enough to occlude the coronary arteries. The apparatus was thoroughly rinsed and the filter
changed between each heart. The aortic cannula has an opening through which pressure
tubing connects it a transducer (Novatrans II pressure transducer; MedexInc, Hillard, OH).
The pressure tracing and beating rate were recorded on an intensive care monitor (Spacelab
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90623A; Redmond, WA). Cardiac output was recorded by collecting the aortic flow (AF) in
a burrel pipette and the coronary flow (CF) measured as it drips off the heart. Together AF
and CF determine CO. Heart rate is recorded by counting the aortic deflections. Stroke
volume is derived by dividing CO by HR. After a 20 minute stabilization period, from the
time of placement in the working mode, was observed. Measurements were obtained at 5
minute intervals.

Figure 5. Isolated left heart perfusion
apparatus. The heart sits in the buffer
cannulated at the aorta and left
atrium. Buffer is ejected through the
damping chamber and aortic flow
tubing (afterload). It is collected as
aortic outflow. The buffer is
oxygenated in the atrial reservoir the
height of which determines preload.
To determine afterload the bath is
lowered and the effluent from the heart
is collected. To perfuse the heart as a
Langendorff preparation the
Langendorff column is opened and the
atrial tubing closed off. (Diagram used
and modified with permission of RC
Hill).

In the experiments where the rate of isometric tension generation was determined (i.e.
V dP/dt max and min), the method of Apstein (Apstein et. al., 1977) was used. Briefly this
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method is as follows: The heart was again placed into the Langendorff perfusion mode and
the left atrium removed from the atrial cannula. Via the opening in the left atrium, a latex
balloon tipped catheter was inserted through the mitral valve into the left ventricle. This
catheter was attached to the pressure transducer which, in this experiment, was connected to
the MacLab apparatus. By adjusting the amount of volume (saline) in the balloon, preload or
left ventricular end-diastolic pressure, could be established. In these experiments the heart
was paced with a stimulator (Grass S48; Astromed; W. Warwick, RI) via an electrode placed
on the right atrium. The minimum voltage necessary to capture the heart was used, generally
1-3 Volts. The left ventricular developed pressure (LVDP) was determined as the maximum
systolic pressure. The Chart software calculates the first derivative of the pressure tracing in
order to determine V Dp/dt max.
In those experiments in which drug was added to the isolated heart preparation it was
added directly to the buffer bath. The recirculation time was noted to be approximately 5
minutes. All measurements were carefully recorded at the exact time from the addition of the
drug. In all experiments, except the isoproterenol concentration response curve and the
propranolol concentration response curves, only one dose of drug was administered in vitro.
The concentration response curves for isoproterenol and propranolol were cumulative.
Isolated Right Atria Preparation
In the experiment that utilized the isolated right atrial preparation the animals were
anesthetized, the hearts extirpated and arrested in a manner identical to that described for the
in vitro cardiovascular preparation described above. After the excised heart was arrested the
right atrium was dissected free from the remainder of the heart. Care was taken to avoid
crushing or excessive handling of the atrium. Once it had been dissected free 5-0 silk sutures
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were gently tied to opposite ends of the atrium. The atria were then placed in water jacketed
organ baths containing KH buffer bubbled with 95% oxygen 5% carbon dioxide maintained
at 37°. The suture was attached to a Grass FT .03 force-displacement transducer.
Contractions of the spontaneously beating right atrial preparations were passed via a Grass
polygraph to the MacLab where the tracings were digitized. The heart rates were calculated
off line utilizing the Chart software. All atria were provided with at least a 40 minute
stabilization period. Four atria, determined at random, could be examined simultaneously via
separate organ baths. The isoproterenol dose response curves were begun after the recording
of the basal heart rates (5 minutes after the stabilization period). The cumulative
concentration response curve was observed for single log units by adding 10µl of appropriate
concentrations of isoproterenol HCl to the 10 ml organ bath to bring the final concentration
from 10-16 to 10-5. The HR was determined four minutes after the addition of each successive
dose. Four minutes after the completion of the dose response curve the water bath was rinsed
four times by adding 10 ml of fresh KH buffer and then immediately draining it. The HR
was recorded every 5 minutes for one hour after this wash. Every 15 minutes within this
time period the baths were again rinsed with fresh KH buffer.
Western Blots
The heart were extirpated in a fashion identical to that described above, placed on the
Langendorff perfusion apparatus and perfused with warm KH buffer for approximately two
minutes. This was done to flush the heart of any blood. The right atrium was then excised,
placed in tinfoil and snap frozen in liquid nitrogen. All specimens were stored at -80° for
further analysis. On the day of protein isolation the specimens were quickly weighed and
placed in 1.0 ml of protease inhibitor buffer (PIB) per 100 mg of tissue. The PIB consisted
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of 0.25M sucrose, 1.0 mM EDTA, 4.0 mM phenylmethylsulfonyl flouride, 1.0 mM
aminobenzamidine and 1 mg/ml of bacitracin. At this point tissues were homogenized by
hand utilizing a Duall tissue grinder. The homogenate was microcentrifuged for 5 seconds to
remove nonhomogenized tissue. The supernatant was transferred to fresh Eppendorf tubes
and refrozen as individual aliquots to avoid repeated freeze-thawings. On the day of western
blotting the tubes were thawed and microcentrifuged at 14,000 rpm for 15 minutes. A single
aliquot of the supernatant was used for protein determination by the method of Bradford
(Bradford, 1976). Based upon this determination each sample was diluted in Laemmli
sample buffer (Amersham Life Science; Piscatway, NJ) to equal dilutions. Five µl of
specimen and sample buffer containing 4 µg of protein were then loaded into wells of a 15
well 10% Tris-HCl minigel (Biorad Laboratories; Hercules, CA). Electrophoresis was
performed at constant voltage (115 mV) in Tris/glycine/SDS running buffer (Biorad
Laboratories; Hercules, CA) for approximately one hour. The separated proteins were
immediately transferred to polyvinylidene diflouride sequencing membrane (Biorad
Laboratories; Hercules, CA) using a HEP-1 semi-dry transfer apparatus (OWL Scientific
Plastics) using a constant current of 200 mA for one hour. Transfer was carried out between
two gel blotting papers (Schleicher & Schuell; Keene, NH) soaked in transfer buffer. The
transfer buffer consisted of 39 mM glycine, 48 mM Tris base, 0.037% SDS and 200ml of
methanol brought to one liter and a pH of 8.3. After transfer the membranes were allowed to
dry completely and then washed with phosphate buffered saline containing 0.1% Tween-20
(PBST). Following this the membranes were blocked for one hour with 3% dry milk in
PBST. The membranes were again washed and the primary antibody (mouse anti-PKA-C;
Transduction Laboratories; Lexington, KY) at a concentration of 1/1000 with 3% bovine
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serum albumin (BSA) in PBST was applied for one hour. The membranes were again
washed and a goat-anti-mouse-HRP conjugated secondary antibody (Biorad Laboratories;
Hercules, CA) was applied for one hour at a concentration of 1/3000. At the completion of
the secondary antibody exposure the membrane was washed and protein detection was
carried out with an enhanced chemiluminesence system (ECL, Amersham Life Science;
Piscataway, NJ) and developed on Hyperfilm ECL film (Amersham Life Science.)
Quantification of protein was determined by the densitometric analysis of the western
blots. Briefly the blots were place on a light source (Precision illumination model B90,
Imaging Research Inc.; St. Catherines, Ont.) and captured with a Dage CCD 72 camera
(Dage; Michigan City, IN). Boxes were hand drawn with around each blot utilizing a PC and
mouse. The inverse log of the integrated gray value (the mean gray value x area) was
determined with Optimas imaging software (Optimas Corp.; Edmunds, WA). Two control
animals and two animals for each treatment group were present on each blot in order to
control for variability in the processing. The experiment was duplicated at separate time
points. The final analysis was therefore conducted on three separate protein aliquots for four
animals in each treatment group. All densitometric units were normalized to the average of
the two controls on each blot.
Heart Rate Variability
The heart rate variability studies were performed on electrocardiogram (ECG)
tracings from conscious rats. Rats were anesthetized with Telazol and subcutaneous wires
(.010 in. PVC coated wire, Belden; Geneva, IL) were sutured to either side of the chest
wall. The wires were tunneled subcutaneously to the nape of the neck and brought out
through the vest, hub and spring combination utilized in the in vivo cardiovascular
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preparation. The animals recovered in the plexiglass foot shock chamber for 24 hours prior
to the beginning of the experiment. In four animals a control ECG tracing was then recorded
continuously for 24 hours by attaching the electrodes to the SpaceLab intensive care unit
monitor and recording ECG lead I. The analog ECG signal was passed from the SpaceLab
monitor to the MacLab where the tracing was sampled at 400 samples per second, digitized
and recorded on the hard drive. After 24 hours the animals were injected with LPS 5 mg/k
i.p. and their ECG tracing recorded for an additional 16 hours. The heart rate variability
(HRV) extension of the Chart software was programmed to take equally spaced 5 minute
samples from each of the 40 hours for time and frequency domain analysis. The other five
animals were handled identically with the exception that ECG was not recorded continuously
but instead five minute recordings were taken at 24, 20, 16, 12, 8, 4 and 1 hour before LPS
administration and every hour for eight hours and then 12 and 16 hours after LPS.
All of the five-minute samples were examined for a stationary baseline or significant artifact.
If this existed the sample was rejected and another five-minute tracing was obtained. All
samples were processed utilizing the Chart software in accordance with the “Heart rate
variability: standards of measurement, physiological interpretation, and clinical use” from
the Task Force of the European Society of Cardiology and the North American society of
Pacing and Electrophysiology” (Malik, 1996). Detection of the R wave was performed on
the derivative of the ECG tracing to eliminate respiratory artifact. The Chart program allows
for the manual setting of the threshold of R wave detection with a precise fiducial point. All
RR intervals between 100 and 200 ms were included, ectopics were excluded and artifacts
manually edited. Measurements calculated in the time domain included the standard
deviation of all normal RR intervals (SDNN) and the root mean of the sum of squares of
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differences between adjacent RR intervals (RMSDD). The power spectrum was calculated
with fast Fourier transformation by automatic resampling of the tachogram generated via the
above method . The algorithm included linear interpolation, no overlapping and the use of a
Hann window. The power spectrum was calculated on a 512 point segment. The low
frequency (LF) was set at 0.1 Hz to 0.8 Hz and the high frequency (HF) as 0.8 to 3 Hz. The
parameters calculated included the LF and HF variability, the ratio LF/HF and the
normalized units of HF (HF nu) and LF (LF nu). HF nu and LF nu were calculated by
dividing HF and LF by total power (measure of total variability) after subtracting the very
low frequency variability from the total power.
Statistical Analysis
The method of statistical analysis was an analysis of variance (ANOVA) except for
those instances where Student’s t-test or regression analysis were appropriate. In general, the
ANOVA model utilized was a modified split plot design with repeated measures. The error
term consisted of animals nested within treatments. Treatments (LPS or saline and drugs)
and time were handled individually and as factorials in order to test for interactions among
the variables. In some experiments heart rate was used as a covariate to control for its effects
on contractile function. Multiple comparisons within the ANOVA were made only when the
F test indicated it to be appropriate. At this point comparisons were made with orthogonal
contrasts. The p value of the t-test of these contrasts required for significance was
determined by dividing the alpha value (0.05) by the number of comparisons made according
to the method of Bonferroni (Tukey, 1949; Kramer, 1956). This method of multiple
comparisons does not require that n values for each treatment group be equal. In those
instances where one-way ANOVA was performed, the Tukey-Kramer test was used for
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multiple comparisons. All analyses were carried out using JMP statistical software (SAS
Institute, Research Triangle Park, NC).
Dose response curves were fitted and graphed with Prism software (GraftPad
Software, Inc.; San Diego, CA). The ED50 and EC50 values were calculated as geometric
means with 95% confidence intervals according to the method of Fleming (Fleming et. al.,
1972).
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RESULTS
Characterization of the model
a. In vivo cardiovascular changes following endotoxin
By four hours following the administration of endotoxin the animals generally moved
less and appeared lethargic. Endotoxin treated animals had stopped grooming behavior and
drank less than control animals. Septic animals demonstrated piloerection, somewhat
labored breathing and frequently their eyes became encrusted with exudates. These findings
were progressive over time. The mortality rate following the bolus endotoxin injection was
approximately eight percent and, for the most part, occurred within the first 12 hours. In
examining 204 of the rats used in these experiments the initial weights were not significantly
different, however there was a 4.8% average weight loss in those animals treated with
endotoxin which was significantly different from a gain of 0.6% that was seen in the control
animals (table 1).

Pre Weight (grams) Post Weight (grams) % Change in Weight
Control
410 ± 4.6
412.3 ± 4.5
+0.6 ± 0.2
LPS
418 ± 3.8
398.4 ± 3.7
-4.8 ± 0.1
p = 0.1592
p = 0.0178
p < 0.0001
Table 1. Demonstrates the starting weight (pre-weight), weight at the time of sacrifice
(post-weight) and % change in weight for control and endotoxin (LPS) treated animals 16-20
hours after LPS. These data are from 204 animals that received only saline or LPS
pretreatment. The R2 for % change in weight = 0.64.
Eight animals underwent the placement of left femoral artery catheters for the purpose of
studying the time course of blood pressure and in vivo heart rate changes in the twenty four
hours following 5 mg/kg endotoxin administration. This model of endotoxemia
demonstrated no significant changes in blood pressure for the full 24 hours and in vivo HR
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was not significantly elevated until fours after the i.p. dose of LPS after which it remained
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Figure 6. In vivo changes in heart rate (HR) and blood pressure (BP) for 3 hours before and
24 hours following LPS administration (dotted vertical line). Blood pressure is not
significantly altered throughout the time course. HR becomes elevated at 5 hours and
remains elevated through 24 hours (p < 0.05). Error bars represent ± SEM.
It should be noted that this tachycardia is a sinus tachycardia based upon ECG tracings. In
electrocardiogram tracings obtained from septic animals there was a constant P wave and no
alterations in the P-R interval were found while the P-P interval was significantly reduced
(data not shown).
b. Determination of intrinsic heart rate
The finding of an in vivo tachycardia following endotoxin administration was
anticipated. The next experiments were conducted to determine if any of the increase in HR
was related to an elevation of the intrinsic heart rate (IHR). The first experiment designed to
address this issue was the administration of atropine and propranolol to achieve complete
autonomic blockade according to the method of Cavero (Cavero et. al., 1976). In reviewing
the literature, the previous doses of drugs used for this purpose, in the rat, ranged from 1
mg/kg - 10 mg/kg i.v. for propranolol and 200 µg/kg – 4 mg/kg i.v. for atropine (Ackerman
et. al., 1987; Horowitz and Meiri, 1993; Machado and Brody, 1989; Machado et. al., 1987;
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elevated for the remainder of the time monitored (figure 6).

Muntzel and Peterson, 1997; Soato and Krieger, 1974). We conducted preliminary
experiments in which doses above 8 mg/kg of propranolol resulted in no additional slowing
of the heart rate and doses of atropine above 1 mg/kg yielded no further increase in HR.
These doses were consistent with previous studies in the literature and were employed in the
experimental paradigm.
Figure 7 demonstrates the change in HR following the administration of atropine (1
mg/kg). There was little parasympathetic tone in the anesthetized animal as evidenced by the
very slight increase in HR with atropine (figure 7).
IN VIVO - ATROPINE 1MG/KG
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Figure 7. Demonstrates the change in HR following the administration of atropine (1 mg/kg)
to anesthetized rats in vivo 16-20 hours after LPS (5 mg/kg) or saline. Atropine was
administered between 0 and 1 minute. HR remained significantly different p <0.05 at all time
points. Error bars represent ± SEM.
An equal number of rats were administered propranolol first, these results are shown below
(figure 8). Those animals administered propranolol clearly demonstrate that the major
autonomic tone in the anesthetized rat is sympathetic. The effect on HR following
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propranolol treatment remained parallel, however, suggesting that the increase in HR in LPS
treated animals is not due to sympathetic influences.
IN VIVO - PROPRANOLOL 8MG/KG
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Figure 8. Demonstrates the change in HR following the administration of propranolol (8
mg/kg) to anesthetized rats in vivo 16-20 hours after LPS (5 mg/kg) or saline. Atropine was
administered between 0 and 1 minute. HR remained significantly different p <0.05 at all time
points. Error bars represent ± SEM.
At 10 minutes after the administration of atropine or propranolol all animals then received
the second agent, resulting in blockade of both components of the autonomic nervous system
and revealing the intrinsic heart rate. Ten minutes after administration of the second agent
the intrinsic heart rate or HRo was recorded. The initial heart rate before the administration
of any drug was 19% greater in endotoxin treated animals. After the administration of both
atropine and propranolol there was a 21% difference in the HRo. Interestingly, however,
there was also no difference in the sympathetic and parasympathetic inputs to the in vivo
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heart rate (Table 2). These data suggested that all of the difference in heart rate, as a
percentage change caused by endotoxin was due entirely to changes in the intrinsic heart rate.
TREATMENT
Control
LPS

HRn
HRo
%S
%V
327 ± 11
246 ± 6
39 ± 4%
-14 ± 2%
390 ± 11
299 ± 6
35 ± 5%
-12 ± 2%
p = 0.0005
p < 0.001
p = 0.50
p = 0.069
Table 2. Relative contributions to HR via the sympathetic and parasympathetic nervous
systems. HRn = initial HR. HRo = intrinsic heart rate. %S = sympathetic contribution to
HR. % V = parasympathetic contribution to HR. HR’s are represented as beats per minute
(bpm ± SEM). n = 12 rats/group
Autonomic transmission at both the sympathetic and parasympathetic ganglia is via
acetylcholine binding at nicotinic receptors. Antagonism of these receptors with
hexamethonium (40 mg/kg) should duplicate the surgical excision of the heart at the level of
the ganglia by inhibiting autonomic input to the heart. In a separate set of animals exposed to
endotoxin or saline 16-20 hours earlier, hexamethonium did not abolish the difference in HR.
The heart rate following endotoxin treatment was 23% higher than the HR of control animals
(table 3).
TREATMENT
HRn
HRhex
Control
358 ± 11
272 ± 9
LPS
409 ± 10*
334 ± 10*
Table 3. In vivo HR before and after the administration of hexamethonium (40 mg/kg
i.v.) to anesthetized rats. HRn = initial HR, HRhex = HR 15 minutes following
hexamethonium treatment. LPS (5 mg/kg was administered 16-20 hours prior to
anesthesia and recording of HR. HR (bpm ± SEM). * = different from control p < 0.01.
n = 7 per group
This experiment confirms the earlier findings of an elevation of intrinsic heart rate,
although it does not exclude the possibility of circulating catecholamines (epinephrine)
effecting the heart rate. Neither method of pharmacologic denervation removes the heart
from the presence of humoral substances, other than catecholamines, which could
influence the HR. Excision of the heart, and perfusion with oxygenated buffer as an
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isolated working heart, does provide an experimental means to abolish both neural and
humoral influences on the heart.

c. Determination of in vitro heart rate
Animals were again treated with LPS or saline 16- 20 hours prior to the administration
of anesthetic. After adequate anesthesia was obtained, the hearts were extirpated and
perfused as working left heart preparations and allowed to beat at their intrinsic rate. An
equilibration period of 20 minutes was observed prior to the study of rate. In examining
153 rats (76 control, 77 LPS) that had no treatment other than LPS or saline before
excision of the heart and recording of the in vitro HR, the LPS treated animals had a
17% higher rate (Table 4).
HR (bpm)
CONTROL

238 ± 3.6

LPS

278 ± 3.6*

Table 4. Heart rate (HR) in beats per minute 16 – 20 hours following endotoxin
administration (5 mg/kg). HR shown as bpm ± SEM. HR values represent one reading
at 20 minutes after isolation of the heart. * = significantly different from control (p <
0.0001)
For sixteen rats the in vitro HR was followed for 40 minutes after the initial
stabilization period, or for one hour total after excision. In those animals treated with
LPS the HR was 267 ± 7 bpm compared to a rate of 237 ± 6 bpm for the control animals
(p = 0.002). As can be seen in figure 9, there is no effect of time (i.e. the HR line is
linear, p = 0.99) after the stabilization period and the in vitro HR remained elevated for
at least one hour following extirpation (figure 9).
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Figure 9. Demonstrates the in vitro HR following a single dose of LPS 16 hours prior.
LPS HR is significantly greater than control. (p =0.0002, n=7 per group). Error bars
represent ± SEM. The two lines are parallel to each other (p = 0.99)
In the course of these experiments two variables were identified, other than the
experimental variable, LPS treatment, which effected HR. These variables were weight
and anesthesia. The effect of basal weight on the in vitro HR was examined from the
data of 152 animals. Regression analysis showed a decrease of 0.2 beats per minute for
each gram increase in body weight. The p value for this regression line was p = 0.0176
however the R2 was only 0.037. This suggests that while weight is a significantly related
to the in vitro HR in our experiments it only explains 3.7% of the total variability in HR.
It should be noted that in none of the experiments was the basal weight significantly
different between treatment groups. Because of this lack of difference in initial weights,
and because of the small predictive value of weight, this parameter was not included in
any of the statistical models. As was noted in the methods, the anesthetic used was
changed from pentobarbital to Telazol during the course of these experiments. To
examine the effect of anesthetic on in vitro HR an analysis was performed on 78 rats
having either pentobarbital or Telazol as their anesthetic. The heart rate following
pentobarbital was 237 ± 7 compared to 265 ± 8 for Telazol. This difference of 28 beats
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per minute, or 11.8% is significantly different (p < 0.0001). However, there was no
interaction between anesthetic and treatment in the statistical model (p = 0.73),
indicating that the anesthetic effect was equal between treatment groups (figure 10).

Effects of Anesthetic on In Vitro HR
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Figure 10. This figure shows the relative effects of anesthetic on in vitro HR. Both
anesthetics were administered 16 – 20 hours after LPS (5 mg/kg) or saline.
Pentobarbital was given at a dose of 40 mg/kg i.p. and Telazol at30 mg/kg i.p. Analysis
of variance showed a significant anesthetic effect (p < 0.0001) but no interaction
between anesthetic and treatment (p = 0.7321). n = 78
In none of the experiments was more than a single anesthetic used and anesthetic was
therefore not included in the statistical models. The possibility existed that the elevation
of in vitro HR was due to the unstimulated release of catecholamines while the heart was
on the perfusion apparatus. In order to rule out this possibility the nonspecific βAR
antagonist, propranolol, was added directly to the recirculating buffer at several
concentrations. After a 20 minute stabilization period the in vitro HR was again
recorded, then propranolol was added to the recirculating buffer to achieve a final
concentration of 1 µM. At this concentration, while there was a significant decrease in
HR in both groups, the HR of the LPS treated animal remained significantly greater than
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control. At a concentration of 10 µM, however, the difference between LPS treated and
control animals was abolished (figure 11). This observation and the observation that 1
µM caused a significant decrease in the HR in both groups suggested that there was
ongoing stimulation of the βAR in vitro.

In Vitro HR Response to a
Racemic Mixture of Propranolol
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Figure 11. Demonstrates the in vitro dose response curve to increasing doses of RS
– propranolol added directly to the bath. LPS animals were treated in vivo with 5
mg/kg of E. coli endotoxin 16 –20 hours prior. Pre (basal) heart rates (HR) in beats
per minute were recorded after a 20 minute stabilization period. Other HRs were
recorded 15 minutes after adding the drug. Error bars represent ± SEM.
Some βAR antagonists, including propranolol have non-specific, or membrane
stabilizing properties, which are not related to antagonism of the βAR. These properties
could result in a decrease in the HR. It has been shown, however, that this effect
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is observed with both the active and inactive isomers of propranolol (Doggrel, 1990). In
order to determine if the decrease in HR that was observed in vitro with racemic
propranolol was due to this non-specific effect, concentration response curves to the
inactive isomer of propranolol were conducted in the same fashion as above (Figure 12).

In Vitro HR Response to the
Inactive Isomer of Propranolol
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Figure 12. In vitro dose response curve to increasing doses of the inactive R (+) isomer
of propranolol added directly to the bath. LPS animals were treated in vivo with 5
mg/kg E. coli endotoxin 16 –20 hours prior. Pre (basal) heart rates (HR) in beats
per minute were recorded after a 20 minute stabilization period. Other HRs were
recorded 15 minutes after adding the drug. Error bars represent ± SEM.
With the inactive isomer, a concentration of 1 µM did abolish the difference in HR
between LPS and control animals. There was a further decline of heart rate with the 10
µM concentration. These data suggested that at the 1 µM and 10 µM concentrations, the
effects observed with the racemic mixture were likely due to actions not related to βAR
antagonism and that the elevation of in vitro HR was not due to the presence of
catecholamines. It has been suggested that α-adrenoceptor stimulation can result in a

82

positive chronotropic response (DeLuca and Rand, 1988; Flavahan and McGrath, 1981).
To rule out the unlikely possibility that catecholamines were present and acting at the αadrenoceptor and that this resulted in the increase in in vitro HR an experiment was
conducted antagonizing both the αARs and βARs simultaneously. Animals were again
treated with LPS or saline, the hearts extirpated and perfused. Exposure of the isolated
heart to a concentration of 0.1 µM propranolol and 0.1µM phentolamine, a nonspecific

HR (beats per minute)

αAR antagonist, did not abolish the LPS induced increase in HR (Figure 13).
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Figure 13. Response of in vitro HR to propranolol 0.1µM and phentolamine 0.1 µM
added to the bath at the broken vertical line. Animals had been treated in vivo with 5
mg/kg endotoxin (LPS) or saline (Control) 16 – 20 hours earlier. Error bars represent ±
SEM. LPS line is significantly greater than control p < 0.0001.
These experiments demonstrated that there was an increase in the in vitro heart rate in
addition to the increase in the IHR as measured by pharmacologic denervation.
Together this suggests that there is a resetting of IHR in animals exposed to a single
bolus of endotoxin. The reader will recall from the introduction that to date this type of
long term change in IHR has only been demonstrated as decreases in IHR observed in
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both exercise training and with age. The goal of the next series of experiments was to
explore and determine the mechanisms by which the resetting of the IHR occurred.

Mechanism of Induction of Increased Intrinsic Heart Rate
a. Reserpine Inhibition
The only well known mechanism by which HR is increased is via an increase in the
activity of the sympathetic nervous system or a withdrawal of parasympathetic tone.
Previous studies have indicated that, in response to endotoxin, there is a surge in
catecholamine levels. It was hypothesized that inhibition of this increase in
catecholamine levels would prevent the increase in IHR. Appropriate doses of
reserpine, an inhibitor of adrenergic vesicular uptake, are known to deplete an animal of
catecholamines over time. Reserpine treatment was employed as a means of depleting
animals of catecholamines and thereby preventing the increase in HR induced by
endotoxemia. Using a dosing regimen that has previously been demonstrated to deplete
95% of the myocardial catecholamines in rats, 1 mg/kg/day for 2 days (Rice et. al.,
1987) we examined HR following LPS administration. Animals were dosed 32 and 8
hours prior to the administration of endotoxin with 1 mg/kg reserpine or sham vehicle.
Equal numbers from each group then received either LPS (5 mg/kg) or saline sham.
Sixteen hours later the animals were anesthetized and the in vivo HR recorded. The
hearts were then extirpated and perfused as working left heart preparations and in vitro
HR recorded. As demonstrated in figures 14 and 15, reserpine pretreatment abolished
both the in vivo and in vitro differences in HR induced by LPS.
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Figure 14. In vivo HR 16 – 20 hours after LPS (5 mg/kg) or saline (NS) sham.
Thirty-two and 8 hour prior to LPS animals received reserpine (Res, 1 mg/kg) or an
equal volume of sham vehicle (Sham). Error bars represent SEM. Sham/LPS is
significantly greater than all other groups (p < 0.05, n = 6 per group).
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Figure 15. In vitro HR 16 – 20 hours after LPS (5 mg/kg) or saline (NS) sham. Thirtytwo and 8 hour prior to LPS animals received reserpine (Res, 1 mg/kg) or an equal
volume of sham vehicle (Sham). Error bars represent ± SEM. Sham-LPS line is
significantly greater than all other lines (p = 0.04, n = 6 per group). Other lines are
not different from each other.
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In this experiment, using a statistical model to correct for differences in HR, no significant
differences were observed among groups in the in vitro cardiac output (CO), coronary flow
(CF), velocity of aortic flow (A dP/dt) or cardiac output times peak systolic pressure (CO x
PSP), a measure of the ability of the heart to perform work (Table 5).

Sham-NS

Sham-LPS

Res-NS

Res-LPS

p

HR (bpm)

238 ± 6

282 ± 6∗

237 ± 6

246 ± 7

0.0482

CO (ml/min)

103 ± 5

89 ± 6

95 ± 5

97 ± 4

0.1559

CF (ml/min)

5.15 ± .37

6.07 ± .50

5.54 ± .39

5.98 ± .33

0.5360

A dP/dt

1040 ± 77

1068 ± 102

1122 ± 83

1042 ± 70

0.3950

CO x PSP

7567 ± 387

6351 ± 400

7438 ± 362

6966 ± 362

0.1384

Table 5. In vitro cardiovascular parameters 16-20 after LPS (5 mg/kg, i.p.) or saline
(NS). Equal numbers of animals were pretreated with reserpine (Res, 1 mg/kg) or
vehicle (Sham) 32 and 8 hours before LPS or NS. HR = heart rate, CO = cardiac
output, CF = coronary flow, A dP/dt = aortic dP/dt, CO x PSP = cardiac output x peak
systolic pressure. Error is ± SEM. The p value represents the ANOVA for the combined
treatment effect (Sham or Res combined with LPS or NS). * = significantly greater than
all other treatments p < 0.0083.
The administration of a single dose of reserpine 8 hours prior to endotoxin was not sufficient
to abolish the endotoxin induced increase in in vitro HR observed 16 hours later (figure 16).
This lack of effect was most likely due to insufficient depletion of catecholamines prior to
the administration of endotoxin.
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Figure 16. In vitro HR following a single dose of reserpine (RES, 2 mg/kg) 8 hours prior to
LPS or saline (NS) administration. Animals were sacrificed and hearts studied 16 hours
after LPS or NS was administered in vivo. Error bars represent ± SEM. The separation
between the lines is approaching significance at p = 0.053 (n = 5/group).
The reserpine data demonstrated that substantive depletion of catecholamines prior to the
administration of LPS could abolish the LPS induced increase in intrinsic heart rate. We
hypothesized that the persistent elevation of the intrinsic heart rate must therefore be
mediated by catecholamines. However, this increase outlasted the ongoing presence of
catecholamines, as evidenced by the failure of propranolol to abolish either the in vivo or in
vitro increase in HR once initiated. Reserpine can be directly toxic to the myocardium and it
has been shown to cause depletion of other neurotransmitters, particularly serotonin or 5-HT
(Heslop and Curzon, 1994; Iwayama et. al., 1973; Jandhyala et. al., 1971; Nagata et. al.,
1987). To ascertain whether catecholamines caused the increase in intrinsic heart rate via the
βAR, or whether reserpine abolished the difference in HR because of its noncatecholaminergic effects, animals were exposed to endotoxin during continual antagonism
of the βAR.
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b. Inhibition of increased intrinsic heart rate by β adrenoceptor antagonism
To determine if the effects of reserpine were due to depletion of other neurotransmitters
or toxic effects of the agent, animals were pretreated with a βAR antagonist prior to exposure
to endotoxin. If this experiment also abolished the increase in HR, the intrinsic tachycardia
of sepsis was likely mediated by an effect of the sympathetic neurotransmitter via the βAR.
The proper dosing of reversible competitive antagonists in order to completely block the
receptor for 16 – 20 hours can be difficult to achieve. In this instance the problem is
compounded by the markedly increased and varying levels of agonist, and the nonspecific
effects of many βAR antagonists at higher doses. An irreversible noncompetitive receptor
antagonist is easier to employ because once adequate antagonism is achieved the duration of
action depends only on the rate of receptor turnover. Bromoacetyl alprenolol menthane
(BAAM) is an irreversible βAR antagonist. BAAM has been reported to bind both β1 and
β2 adrenoceptors with a duration of action of several days (Doggrell, 1990b). A dose of 35
mg/kg has been demonstrated to block greater than 85% of the βARs in the rat heart, with
receptor populations not returning to normal until 100 hours later (Baker and Pitha, 1982).
Preliminary experiments were conducted in order to determine the appropriate dose
for our model. We found that one hour after the administration of 40 mg/kg BAAM i.p. to
naïve rats there was no response to 0.1 mg/kg of isoproterenol, a greater than maximal dose.
Eight hours following a single dose of BAAM (40 mg/kg) decreased responsiveness to βAR
stimulation still remained (Figure 17).
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Figure 17. Heart rate (HR) response to i.v. isoproterenol in the conscious unrestrained rat 8
hours after a single dose BAAM (40 mg/kg i.p.) The isoproterenol ED50 pre-BAAM is 1.18 x
10-5 mg/kg and 8 hours post BAAM it is 1.92 x 10-4 mg/kg (p < 0.05, n = 3 per group).

A separate group of animals was followed for 24 hours after a single i.p. dose of BAAM (40
mg/kg). Unlike the observations from the literature outlined in the introduction, we found
that 24 hours after the administration of BAAM there was supersensitivity to isoproterenol
(figure 18). These data should be interpreted with some caution, however, because the
isoproterenol ED50 for BAAM administration in this group of animals was equal to the
isoproterenol ED50 eight hours after BAAM in the previous series of experiments. This may
reflect the small numbers of animals (n = 3 per group) used in these preliminary experiments.
What is clear, is that 24 hours following a single dose of BAAM the HR response to
isoproterenol was no longer inhibited.
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Figure 18. Isoproterenol dose response curve before and 24 hours after BAAM (40 mg/kg,
i.p.) There is no change in maximum response. Isoproterenol ED50 pre-BAAM is 1.35 x 104
mg/kg and 24 hours post is 1.38 x 10-5 (p < 0.05, n = 3 per group).
The goal of these experiments was to inhibit the βAR until at least the point when the
elevation in intrinsic heart rate was observed which was 16-20 hours after endotoxin.
Knowing that the BAAM remained effective at 8 hours, a group of animals that had received
BAAM was adminstered a second dose of BAAM (40 mg/kg) eight hours after the first
dose. Twelve hours following this second dose, or twenty hours after the first dose, HR dose
response curves to isoproterenol were repeated. Using this dosing regimen the HR response
to isoproterenol was still decreased at 20 hours (Figure 19).
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Isoproterenol Dose Response Curve
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Figure 19. Heart rate response to i.v. isoproterenol in the conscious unrestrained rat 12
hours after a second dose of BAAM (40 mg/kg i.p.). The first dose had been given 20 hours
earlier and was also 40 mg/kg. There is no difference in the maximum response. The
isoproterenol ED50 pre-BAAM was 1.185 x 10-5 mg/kg and 8 hours post BAAM it is 1.5 x 104
mg/kg (p < 0.05, n = 3 per group).
The observation that the maximum response is not altered by BAAM suggests that either this
agent is not irreversible or that there is a large βAR receptor reserve for the HR response.
Because we had observed some lethality with the 40 mg/kg dose of BAAM increasing the
dose was not a viable option. Instead we proceeded to see if this dosing regimen (40 mg/kg
every 8 hours X 2) would be adequate to prevent the increase in intrinsic heart rate in sepsis.
Animals were fitted with arterial catheters for conscious hemodynamic monitoring.
Thirty minutes after the first dose of BAAM, endotoxin (5 mg/kg, i.p.) or saline was
administered. Blood pressure and HR were followed for 16-20 hours, the animals were then
anesthetized, the hearts extirpated and in vitro cardiac function was examined. This dose of
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BAAM caused a significant amount of mortality outside of the combined effects with LPS
(table 6).
BAAM-LPS

BAAM-NS

ET-LPS

ET-NS

TOTAL

Mortality/Animals

5/10

2/8

1/7

0/5

8/30

% Mortality

50%

25%

14%

0%

27%

Table 6. Mortality associated with BAAM or ethanol (ET) vehicle (40 mg/kg, i.p x 2 doses)
and LPS (5 mg/kg) or saline.

The HR response was examined for a three-hour baseline period prior to the administration
of any drugs. At time zero BAAM or vehicle was first administered and then repeated at 8
hours. LPS was given 30 minutes following the first BAAM injection. Over all of the time

HR (bpm)

periods there is a significant effect of treatment on HR (p = 0.0028)(figure 20).
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Figure 20. Heart rate response to LPS (5 mg/kg, i.p.) or saline (NS) following treatment with
BAAM (40 mg/kg, i.p.) or ethanol vehicle (ET). A three hour baseline (time –3 to 0) was
observed prior to the administration of any drug. BAAM or ET was given at time 0 followed
30 minutes later by LPS or NS. BAAM or ET was repeated at time 8 hours. Error bars are ±
SEM.

There were no differences in mean arterial pressure (MAP) between treatment groups when
examining all time periods (Figure 21).
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Figure 21. Mean arterial pressure (MAP) response to LPS (5 mg/kg, i.p.) or saline (NS)
following treatment with BAAM (40 mg/kg, i.p.) or ethanol vehicle (ET). A three hour
baseline (time –3 to 0) was observed prior to the administration of any drug. BAAM or ET
was given at time 0 followed 30 minutes later by LPS or NS. BAAM or ET was repeated at
time 8 hours. Error bars are ± SEM.
A subset analysis was performed for the time baseline time period as well as time 16-20
hours. The analysis of variance showed that there were no baseline differences between
groups with regard to heart rate (p = 0.08) or blood pressure (p = 0.15). At 16 to 20 hours,
however, there was a significant HR (p = 0.0039) differences between groups but no
significant MAP differences (p = 0.08) (Table 7).
HR (bpm)

MAP (mmHg)

Baseline

16-20 hours

Baseline

16-20 hours

BAAM-LPS

368 ± 9

328 ± 31*

105 ± 4

113 ± 8

BAAM-NS

399 ± 8

408 ± 13#

115 ± 4

120 ± 3

ET-LPS

380 ± 8

463 ± 19

118 ± 4

129 ± 4

ET-NS

374 ± 9

392 ± 23#

117 ± 4

113 ± 6

Table 7. Heart rate (HR) and mean arterial pressures (MAP) at baseline and 16-20 hours
after endotoxin (LPS, 5 mg/kg) or saline (NS). Animals received BAAM (40 mg/kg) or
vehicle (ET) 30 minutes before and 8 hours after LPS or NS. Error is ± SEM and n = 5 to 6
per group. * = significantly less than ET-LPS (p < 0.002). # = significantly less than ET –
LPS (p < 0.03).
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At the completion of the in vivo portion of the experiment the animals were anesthetized and
the hearts extirpated and perfused as working left heart preparations. After a 20 minute
stabilization period the heart rate, cardiac output and coronary flow were recorded every 5
minutes for 20 minutes. The statistical model (R2 = 0.95) demonstrated a significant
difference between treatments (p = 0.036). As demonstrated below, the ET-LPS heart rate
was the greatest and BAAM-LPS the lowest, apparently confirming that BAAM would
prevent an in vitro elevation of HR (figure 22). However, the conservative method of
multiple comparison (Bonferroni) that was used requires a p value (Student’s t-test) less than
0.0083 to demonstrate significant differences for an α = 0.05 if six comparisons are made
(0.05/6 = 0.083). By this conservative method no significant differences were detected by
multiple comparison. This is most likely related to the small numbers of animals (5 to 6) per
group. In general the statistical model we have utilized requires at least 6 animals per group
for sufficient power. For the reader’s benefit the results of the student’s t-tests between
groups are also shown (table 8).
BAAM-LPS

BAAM-NS

ET-LPS

ET-NS

BAAM-LPS

(281 ± 23)

0.4211

0.0198*

0.8071

BAAM-NS

0.4211

(306 ± 21)

0.087

0.5538

ET-LPS

0.0198*

0.087

(359 ± 21)

0.0264

ET-NS

0.087

0.5538

0.0264*

(289 ± 21)

Table 8. Numbers represent the p value from Student’s t-tests comparing in vitro HR
between treatment groups 16-20 hours after LPS or NS. The numbers in bold are the mean
values ± SEM for each treatment. These values apply to the lines in Figure 22. Animals
received BAAM (40 mg/kg) or vehicle (ET) 30 minutes before and 8 hours after LPS or NS
and n = 5 to 6 per group.
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In Vitro HR Following LPS and BAAM
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Figure 22. In vitro heart rate (HR) following in vivo LPS and BAAM. Animals received
BAAM (40 mg/kg) or vehicle (ET) 30 minutes before and 8 hours after LPS or NS in vivo. A
20-minute stabilization period was observed. Error bars are ± SEM. The effect of treatment
was significant (p = 0.036, n = 5 to 6 per group).

At this time point (16-20 hours after LPS) the ET-LPS in vitro HR is 17% greater than the
control animals (ET-NS). This is consistent with the previous observations. Furthermore,
the ET-LPS in vitro HR is 24% greater than the BAAM-LPS. The experimental evidence
strongly suggests that pretreatment with BAAM inhibited the LPS induced increase in
intrinsic heart rate. This observation supports the conclusion that the action of reserpine in
preventing the same elevation of HR was due to the depletion of catecholamines and the
subsequent inability of neurotransmitter to stimulate the βAR.
Coronary flow (CF) and cardiac output (CO) were also examined in the in vitro
preparation. The statistical model, which controlled for the variation in HR, detected
significant differences with respect to treatment for CF (p = 0.0378). There were no
treatment differences with regard to CO (p = 0.0604). The BAAM-LPS group had the lowest
value for both variables (table 9).
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BAAM-LPS

BAAM-NS

ET-LPS

ET-NS

Coronary Flow (ml/min)

12.4 ± 1.4

20.2 ± 0.8*

20.6 ± 2.2

19.1 ± 1.3*

Cardiac Output (ml/min)

72.3 ± 5.6

99.8 ± 3.3

92.56 ± 8.7

86.4 ± 5.0

Table 9. Coronary flow and cardiac output in vitro following LPS and BAAM. Animals
received BAAM (40 mg/kg) or vehicle (ET) 30 minutes before and 8 hours after LPS or NS in
vivo. Error is ± SEM. * = significantly greater than BAAM-LPS p < 0.0083, n = 5 to 6 per
group.
BAAM antagonizes the β2 receptors, which mediate vasodilitation, as well as the β1
receptors which mediate the majority of myocardial effects. The finding of decreased
coronary flow in the BAAM-LPS group suggests that released catecholamines may also play
a role in preserving CF in sepsis. This finding was not observed in the reserpine – LPS
group. The reserpine, however would also have inhibited α - adrenoceptor mediated
vasoconstriction of arterioles. Thus, BAAM may influence CF through an alteration of the
balance between these two processes. The decreased CF could account for the somewhat
lower CO observed in the BAAM-LPS group.
To examine whether BAAM was still effective, in terms of βAR antagonism, at the
time of these observations an isoproterenol concentration response curve was constructed for
the in vitro hearts. The HR concentration response curve is shown below (figure 23). There
was no difference in the HR response to βAR stimulation based upon the calculation of the
geometric mean EC50 and 95% confidence intervals (table 10).
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ET-NS
ET-LPS
BAAM-NS
BAAM-LPS

Figure 23. Heart rate (HR) concentration response curve to isoproterenol in vitro. Animals
received BAAM (40 mg/kg) or vehicle (ET) 30 minutes before and 8 hours after LPS or NS in
vivo. Error is ± SEM. There is no significant difference in maximum response.
Mean EC50
95% C.I.
-9
BAAM-LPS
5.7 x 10
3.7 x 10-10 to 8.9 x 10-8
BAAM-NS
3.2 x 10-8
6.0 x 10-9 to 1.7 x 10-7
-9
ET-LPS
2.5 x 10
1.1 x 10-10 to 5.6 x 10-8
ET-NS
4.6 x 10-8
1.4 x 10-9 to 1.6 x 10-6
Table 10. Geometric mean EC50 and 95% confidence interval for HR response to
isoproterenol. Animals received BAAM (40 mg/kg) or vehicle (ET) 30 minutes before and 8
hours after LPS or NS in vivo. The confidence intervals all overlap.
Based upon these data, the βAR was no longer significantly antagonized by BAAM at a time
at which the in vitro HR was elevated. This implies that the βAR was fully functional in the
BAAM-LPS group and yet neither the in vitro nor the in vivo HR was elevated in these
animals. This provides further evidence that functional βARs are required at an early stage
in the septic process to increase HR but that the later persistent elevation in HR is not
dependent upon continued βAR activity.
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c. Response of reserpinized animals exposed to maximal doses of βAR agonist
The question arises as to whether stimulation of the βAR is required in tandem with
LPS itself, or the accompanying cytokine elevations, early in the septic process to induce the
elevation of IHR. An alternative hypothesis would be that LPS induces a change in the
cellular processes controlling IHR that only becomes apparent after stimulation of the βAR.
If the latter hypothesis were true animals exposed to reserpine and then LPS should develop
an elevation of the IHR if they were subsequently exposed to a βAR agonist. In order to test
this hypothesis animals were pretreated with reserpine as above (1 mg/kg 32 and 8 hours
prior to LPS or NS) and then treated with LPS. Sixteen hours after LPS the right atria were
excised and placed into organ baths. After a 40-minute stabilization period an isoproterenol
concentration response curve was constructed. The isoproterenol was then rinsed from the
bath and the heart rate decay over the following one-hour was examined and compared to
control animals. The treatment groups consisted of Sham-NS, Sham-LPS, Reserpine-NS and
Reserpine-LPS.
The in vivo HR was significantly higher in the Sham-LPS group than the reserpineNS or the reserpine-LPS groups. There were no statistically significant differences in the
basal beating rates of the isolated right atria. The Sham-LPS rate was, however, 17% greater
than the Sham-NS which is in agreement with the previous observations. There were also no
statistical differences in the maximum rate response to isoproterenol or the beating rate onehour after the removal of isoproterenol from the bath (Table 11).
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Treatment

In Vivo HR

Isolated Right
Isolated Right
Isolated Right
Atria Basal HR Atria Max. HR Atria Final HR
Sham-NS
399 ± 21
253 ± 18
455 ± 18
285 ± 16
Sham-LPS
453 ± 21
295 ± 18
418 ± 18
331 ± 16
Reserpine-NS
318 ± 21*
238 ± 18
414 ± 18
300 ± 16
Reserpine-LPS
320 ± 21*
274 ± 18
428 ± 18
325 ± 16
Table 11. In vivo HR and HRs of isolated right atria 16-20 hours after LPS (5mg/kg) or
saline (NS) sham. Animals were pretreated with reserpine or vehicle (sham) 32 and 8 hours
prior to excision of the right atria. Isolated right atria basal HR represents the basal beating
rate 40 minutes after excision. The isolated right atria max. HR is the maximum HR
following maximal concentrations of isoproterenol. The isolated right atria final HR
represents the HR one hour after isoproterenol washout. * = significantly different from
Sham-LPS p < 0.05.
The isoproterenol concentration response curves as absolute values of beating rate are
demonstrated in Figure 24. The curves were also normalized as a percentage of the maximal
increase in beating rate to adjust for the differences in basal rate (Figure 25). As can be seen
from the curves there is no difference in the responsiveness of the isolated atria to
isoproterenol regardless of treatment. The EC50 for the individual treatment groups are
shown in table 12.
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Figure 24. Heart rate (HR) concentration response curve to isoproterenol in isolated right
atria. Animals received LPS or NS 16-20 hours prior. Animals were also pretreated with
reserpine (RES) or vehicle (SHAM) 32 and 8 hours prior to LPS or NS. Error is ± SEM .
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Figure 25. Percentage of maximal change in beating rate concentration response curve to
isoproterenol in isolated right atria. Animals received LPS or NS 16-20 hours prior.
Animals were also pretreated with reserpine (RES) or vehicle (SHAM) 32 and 8 hours prior
to LPS or NS. Error is ± SEM .
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Absolute Beating Rate
% of Maximum Increase in Rate
EC50
95% CI
EC50
95% CI
-10
-9
-10
-9
-9
8.22
x
10
to
3.40
x
10
8.53
x
10
to 3.45 x 10-9
Sham-NS 1.743 x 10
1.716 x 10
-10
-9
6.20 x 10-10 to 3.62 x 10-9
Sham-LPS 1.675 x 10-9 3.74 x 10 to 7.51 x 10
1.499 x 10-9
-10
-9
5.89 x 10-10 to 2.36 x 10-9
RES-NS
1.362 x 10-9 2.86 x 10 to 6.48 x 10
1.288 x 10-9
-10
-9
8.22 x 10-10 to 3.40 x 10-9
RES-LPS 8.854 x 10-10 2.98 x 10 to 2.63 x 10
1.179 x 10-9
Table 12. Geometric mean EC50 and 95% confidence intervals for the HR response of
isolated right atria to isoproterenol. Animals were pretreated with reserpine (RES) or
vehicle (Sham) and then received LPS or NS. The absolute beating rate is taken from figure
24. The % of maximum increase in rate is taken from figure 25. All confidence intervals
overlap.
The Sham-NS group did demonstrate a significantly steeper rate of decline from maximum
beating rate than the other three groups (Figures 26 and 27). This finding relates mostly to
the slightly higher maximum beating rate and the slightly lower finishing rate.
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Figure 26. Decline in HR of isolated right atria from a maximal concentration of
isoproterenol. Animals were pretreated with reserpine (RES) or vehicle (SHAM) 32 and 8
hours prior to the administration of LPS or NS. The right atria were excised 16-20 hours
later and exposed to maximal concentrations of isoproterenol. Following removal of
isoproterenol from the bath the decrease in HR was observed over the next one hour. The
rate of decline of SHAM-NS is significantly steeper than the other three groups (p < 0.05).
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Figure 27. Decline in HR following exposure of isolated atria to a maximum concentration
of isoproterenol. The Sham-NS (broken) line is significantly different from the others
p<0.05. The R2 for each of the lines is Sham-NS = .93, Sham-LPS = .94, Res-NS = .92 and
Res-LPS = .89

Because none of the finishing rates have returned to baseline it is difficult to draw
conclusions as to whether exposure to isoproterenol would elevate the IHR (in this case the
final beating rate) of the reserpine-LPS group. The similarity of the rate of decrease of the
four groups suggests that there is likely no difference in the decay of the response in the
treatment groups with the exception of Sham-NS. While it is possible that both reserpine and
LPS had an effect to slow the decline in HR following exposure of isolated right atria to a
maximum concentration of isoproterenol, the fact that none of the groups returned to the
baseline beating rate suggests that observation for a longer period of time is warranted prior
to drawing this conclusion. The experiment does conclusively demonstrate that there is no
difference in responsiveness with regard to the reserpine pretreatment or the LPS exposure.
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d. Time course of changes in the catalytic subunit of protein kinase A and phospho-CREB
Protein kinase A (PKA) exists in the inactivated state as a heterodimer composed of
two regulatory subunits (PKA-R) and two catalytic subunits (PKA-C). Following the
activation of adenylyl cyclase cAMP is produced. Each regulatory subunit of PKA can bind
two molecules of cAMP (Cooper, 1997). Once four molecules have been bound to the
heterodimer the catalytic subunits are released from the regulatory subunits and PKA-C
becomes active. It is known the PKA-C can act in two ways. It can remain in the cytoplasm
where it phosphorylates a variety of proteins or it can enter the nucleus where it
phosphorylates and activates transcription factors in the cyclic AMP response element
binding protein (CREB) (Tasken et. al., 1997). PKA-C remains active until it is rebound by
PKA-R or until it is degraded by proteases (Hemmings, 1986). Alterations in the levels of
PKA-C have been reported to correlate with the activation of the catalytic subunit by cAMP
(Boundy et. al., 1998; Garrel et. al., 1997). In order to determine the time course of these
changes and whether levels of PKA-C are likely to play a role in the observed elevation in
IHR quantitative western blots were performed. Animals were sacrificed at 2, 4, 8 and 16
hours after LPS or NS pretreatment. Their right atria were processed for quantitative western
blots and density was determined via densitometry. All observations were normalized as a
percentage of the controls ran on the same blot. At two hours after LPS, PKA-C was 113% ±
14% of control, at four hours it was 128% ± 13% of control and at eight hours PKA-C was
112% ± 14% of control. None of these values are significantly different from control levels.
Sixteen hours after LPS, PKA-C levels in the right atrium had decreased significantly to 36%
± 14% of control values. Figure 28 demonstrates a representative western blot and figure 29
provides a graphic depiction of the above values.
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Figure 28. Representative western blot of PKA-C in the right atrium following the
administration of endotoxin. + = positive control, NS = normal saline and 2, 4, 8, and 16
represent hours after endotoxin administration in vivo. Each well represents a separate
animal.
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Figure 29. PKA-C levels in right atria following LPS administration in vivo. Only 16 hours
is significantly different from control represented by the broken line (p<0.0001).
PKA-C levels are not necessarily reflective of PKA catalytic activity nor do they offer any
information as to whether the message has been transduced to the nucleus or remained in the
cytoplasm. The measurement of phosphorylated CREB does, however, offer information
with regard to the degree to which, and time course over which, message has been transduced
to the nucleus. For this reason an antibody specific for phosphorylated CREB was utilized in
the same fashion on different aliquots from the same atria.
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Phosphorylated CREB levels had risen to 300% of control by two hours after LPS, reaching a
peak of greater than 500% of control values by four hours and returning to baseline 16 hours
after LPS administration. Figure 30 demonstrates a representative western blot and figure 31
provides a graphic depiction of the above values.

Figure30. Representative western blot of Phospho-CREB in the right atrium following the
administration of endotoxin. NS = normal saline and 2, 4, 8, and 16 represent hours after
endotoxin administration in vivo. Each well represents a separate animal.
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Figure 31. Phospho-CREB levels in right atria following LPS administration in vivo. The
dotted line represents control.
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e. Time Course of Changes in Heart Rate Variability
Heart rate variability (HRV) has been reported to decrease in septic humans and
rabbits. In order to determine if these changes also occurr in a rat model of endotoxemia
and correlate with observed changes in IHR rats were fitted with subcutaneous ECG
electrodes. Both time and frequency domain measurements of HRV were made prior to
and following endotoxin administration in conscious animals. In agreement with the
previous in vivo experiments the HR did not become elevated until four hours after
endotoxin administration and it remained elevated through the observation period (figure
32).
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Figure 32. Changes in HR following the administration of LPS at time 0. Time is hours
before or after LPS. HR becomes significantly elevated at 4 hours (p<0.05) and remains
elevated at 16 hours after LPS.
Measurements of total HRV included both total power and the standard deviation of all
normal R-R intervals (SDNN) over five minute periods. Both of these measurements
show a drop in HRV beginning two hours after LPS administration and reaching a
maximum at 7 hours after LPS. Normal HRV had not returned at 16 hours after LPS
(figures 33 and 34).
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Figures 33 and 34. Total HRV as measured by Total power and SDNN measured for 5
minute intervals. LPS administration was at time 0. Time is equal to hours before and
after LPS administration. In both measurements HRV is significantly less than control at
2 hours after LPS (p<0.05). HRV decreases further at 4 hours (p< 0.05 when compared
to 2 hours) and then does not change through 16 hours after LPS.
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Parasympathetic tone was measured in both the time domain (RMSDD) and frequency
domain (HF and HF nu) (Figures 35-37). An examination of RMSDD and HF suggests that
there is an initial spike in parasympathetic activity one hour after the administration of LPS
which then declines to below control levels by 4 hours after LPS and remains there
throughout the experimental period. HF nu, which normalizes for the decrease in total HRV,
suggests that parasympathetic tone increases at one hour and remains moderately elevated.
Sympathetic tone, which can only be measured in the frequency domain (LF, LF nu and
LF/HF) (figures 38-40), decreases significantly after LPS as measured by LF. LF nu and the
LF/HF ratio suggest that there is no change in sympathetic activity throughout the
experimental period. These findings are consistent with those authors who found a decrease
in HRV in sepsis (Garrard et. al., 1993; Godin et. al., 1996; Goldstein 1995). Furthermore
the time course of changes agrees closely with our observations regarding intrinsic heart rate.
With the exception of an early increase parasympathetic activity there appears to be minimal
changes in autonomic tone throughout the experimental period. This may relate to the
difficulty in measuring low frequency variability secondary to the large amount of artifact in
the recordings. Our earlier findings with chemical antagonism of the βAR, however, also
suggested minimal difference in the relative sympathetic tone in the control and endotoxin
exposed state. Concern arises as to whether HRV as measured by SDNN and total power is
directly related to HR. If this were the case an increase in HR may simply lower HRV due to
their direct relationship. In order to answer this question linear regression was performed on
HR against these measurements in the control and endotoxin treated state. Interestingly in
the control state there is no relationship between the two but for the time periods after LPS
there is a significant negative correlation (R2 = 0.355, p < 0.0001). This further suggests that
LPS increases the HR outside of the autonomic nervous system and consequently decreases
the influence of this system on HRV.
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Figures 38, 39, 40. Sympathetic
component of HRV as measured
by LF, LF nu and LF/HF. LF
shows a significant decrease in
sympathetic input (p < 0.05) from
2 hours onward. There are no
significant differences in the
autonomic input as measured by
LF nu and the LF/HF ratio. Time
is hour before or after LPS
adminstration at time 0.
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Relationship between inotropic and chronotropic changes
The findings that there is an elevation of in vivo IHR and in vitro HR in sepsis, and
simultaneously that there was a lack of contractile dysfunction is at odds with the literature.
As previously noted there is no standardized model for the study of endotoxemia induced
cardiac dysfunction. Most of the studies that have observed cardiac dysfunction in the rat
have done so after a relatively short duration, approximately four hours after endotoxin
administration, or after continuous exposure to endotoxin or bacteria. In both of these
instances the cardiac dysfunction could be relatively acute in nature. Our model consisting
of endotoxin administration as a single bolus followed by the determination of cardiac
function 16-20 hours later is unique. To examine the time course of HR and contractile
changes following a 5 mg/kg dose of endotoxin the following experiment was conducted.
Rats were randomized to receive either LPS or saline (NS). Equal numbers of animals from
each group were sacrificed four hours or 16-20 hours after endotoxin administration and in
vitro cardiac function was examined. Unlike the previous experiments, after baseline cardiac
function was determined, the hearts were paced at various HRs. The reason for this was twofold: 1) to control for the effect of HR experimentally, rather than statistically; and 2) to
examine the effect of increasing HR on cardiac function at physiologic HRs.
In these rats the in vivo HR in endotoxin treated animals was elevated above control
at both 4 and 16 hours, the in vitro HR was elevated only at 16-20 hours (figure 41). When
examining the difference on a percentage basis the greater elevation of in vivo HR occurs at
16-20 hours and there is the same percentage increase in vitro (table 13).
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HR (bpm)

In Vitro and In Vivo HR Response Following LPS
500
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400
350
300
250
200
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100
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0
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*

*
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LPS In Vivo
CONTROL In Vitro
LPS In Vitro

4

16-20
Time in Hours

Figure 41. Heart rate (HR) in vivo and in vitro both four and 16-20 hours following
endotoxin (LPS, 5 mg/kg i.p.) or saline (CONTROL) in vivo. * denotes significantly different
than control p < 0.05 (n = 7 to 10 per group).
4 HOURS

16 HOURS

In Vivo HR

In Vitro HR

In Vivo HR

In Vitro HR

CONTROL

360 ± 12 (10)

259 ± 8 (10)

375 ± 17 (7)

259 ± 15 (7)

LPS

408 ± 12 (9)

274 ± 9 (9)

448 ± 19 (7)

306 ± 14 (7)

% Difference

13 %

6%

19 %

18 %

p = 0.012

p = 0.214

p = 0.016

p = 0.041

Table 13. Heart rate in beats for minute (HR) observed in vivo and in vitro both four and 1620 hours following endotoxin (LPS, 5 mg/kg i.p.) or saline (CONTROL) treatment in vivo. In
vivo HR was recorded in anesthetized animals. Number in parenthesis is n per treatment
group.
These data demonstrate the consistent (15 – 20%) elevation in both in vivo and in vitro HR at
16-20 hours after endotoxin administration. It further shows that the elevation in in vitro,
and therefore intrinsic, HR is unlikely to be observed at four hours.
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The earlier experiments had demonstrated no contractile dysfunction at 16 hours, as
measured by cardiac output and aortic dP/dt. In examining cardiac output, preload and
afterload were controlled experimentally, and there was a statistical adjustment for HR, so
this should have been a reliable measure of contractility. The maximum rate of ventricular
pressure development (V dP/dt), or the left ventricular developed pressure (LVDP), for a
given preload and HR are recognized as better indices of contractile function. Based upon
these measurements, significant contractile dysfunction was observed four hours after
endotoxin exposure but this reduced capacity had resolved by 16-20 hours (figures 42-45)

CARDIAC OUTPUT 4 HOURS

VENTRICULAR dP/dt max
4HOURS

120

2200

LPS

mmHg/sec

100
ml/min

CONTROL

CONTROL

110
90
80
70

LPS

2000
1800

60
50

1600
300

350
400
HR (bpm)

450

300

350
400
HR (bpm)

Figures 42 and 43. Cardiac output and left ventricular dP/dt max for increasing heart rates
(HR) 4 hours after LPS (5 mg/kg) or saline (Control) administered in vivo. Cardiac output
lines are significantly different (p = 0.03) as are LV dP/dt (p = 0.05)
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450

CARDIAC OUTPUT 16 HOURS

VENTRICULAR dP/dt max 16
HOURS
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Figures 44 and 45. Cardiac output and left ventricular dP/dt max for increasing heart
rates(HR) 16-20 hours after LPS (5 mg/kg) or saline (Control) administered in vivo.
Cardiac output lines are not significantly different (p = 0.96) nor are the LV dP/dt lines (p =
0.86)

It is not clear why the control values for V dP/dt max are not equal at the two time points.
However, since the two experiments were conducted separately, this difference may be a
result of some variability in the apparatus from day to day. When both experiments, 4 and 16
hours after treatment, were analyzed together there is no significant difference between the
two time periods with respect to control animals. The observation of decreased contractility
at 4 hours and not at 16 to 20 hours was consistent regardless of the parameter used to
estimate contractility (table 14).
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450

4 Hours

16 to 20 Hours

NS

LPS

NS

LPS

Cardiac Output (ml/min)

91.3 ± 4.6

81.1 ± 5.3*

86.7 ± 5.1

88.5 ± 4.0

Stroke Volume (ml)

0.256 ± 0.01

0.225 ±0.01*

0.242 ± 0.01

0.245 ± 0.01

Aortic dP/dt (mmHg/sec)

802 ± 60

715 ± 68

910.7 ± 128

1091 ± 117

LV dP/dt (mmHg/sec)

2076 ± 132

1887 ± 132*

1756 ± 171

1799 ± 156

LVDP (mmHg)

102 ± 7.0

95.3 ± 7.0

109 ± 10

109 ± 9

Table 14. Contractile response at 4 and 16 to 20 hours after 5 mg/kg LPS i.p. Numbers
represent the average response for HRs of 300, 350, 400 and 450 determined by electrical
pacing. LV dP/dt and LVDP are for a preload of 15 mmHg. * represents significantly
different from control p < 0.05.

Four hours after endotoxin administration there was a definitive decrease in contractility that
had resolved by 16 hours. As can be seen in the above figures, increasing HR results in a
negative slope for each of the parameters of contractility. Based upon the fit of these lines,
an 18% increase in HR (the average value of the rise in intrinsic rate) at 16 hours would
result in a 13% reduction in CO, a 30% decrease in SV, an 11 % drop in V dP/dt max, a 32%
decline in A dP/dt max and a 17% decrease in LVDP. Therefore, as discussed in the
introduction, increasing HR through mechanisms outside of the autonomic nervous system,
pacing in this case, results in a significant decrease in cardiac function. This directly relates
IHR to cardiac performance and suggests that changes in IHR may directly alter cardiac
function.
Using the reserpine pretreatment regimen that resulted in the abolition of the increase
in IHR (ie. 1 mg/kg 32 and 8 hours before endotoxin) we examined contractile function of
animals sacrificed 4 hours after LPS. Similar to the four hour time course experiments
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described above, endotoxin resulted in a decrease in cardiac function. This decrease in
contractile function was not altered, positively or negatively, by reserpine administration
(table 15).

Effects of LPS Treatment

Effects of Reserpine Treatment by LPS Treatment

NS

LPS

p

Sham-NS

Sham-LPS

Res-NS

Res-LPS

p

HR (bpm)

237 ± 8

274 ± 8

0.008

242 ± 10

268 ± 13

233 ± 11

279 ± 11

0.4

CO (ml/min)

104 ± 7

82 ± 7

0.036

104 ± 9

75 ± 11

104 ± 9

88 ± 9

0.5

CF (ml/min)

20.0 ± 1.6

16.5 ± 1.7

0.15

19.4 ± 2.3

17.4 ± 2.6

21.2 ± 2.3

16.1 ± 2.3

0.5

A dP/dt

1101 ± 82

757 ± 89

0.03

1279 ± 116

868 ± 134

973 ± 116

800 ± 116

0.34

CO x PSP

7432 ± 535

5134 ± 578

0.01

7877 ± 757

5112 ± 874

7702 ± 757

5969 ± 757

0.53

Table 15. In vitro response of contractile parameters to endotoxin and the combined effects
of reserpine and endotoxin administered in vivo. Reserpine (Res) or sham vehicle (Sham)
was administered in vivo (1 mg/kg i.p.) 8 and 32 hours prior to LPS or saline (NS) and
animals were sacrificed 4 hours after LPS or NS. The first two columns show the effect of NS
or LPS across treatments. The p value in the 3rd column refers to the ANOVA with regard to
this treatment. The following four columns show the interaction between the two treatments.
The p value in the last column refers to the interaction between the two treatments. Heart
rate (HR) is in beats per minute (bpm). Cardiac output (CO) is milliliters per minute
(ml/min) as is coronary flow (CF). Aortic change in pressure of change in time (A dP/dt) is
recorded as mmHg/sec. Cardiac output times peak systolic pressure (CO x PSP) is recorded
as ml/min • mmHg. An examination of the ANOVA terms and interaction terms shows that
all of the variability lies within the LPS treatment and that LPS has a negative effect on the
contractile parameters and increases in vitro HR, n = 7 to 8 animals per group.
As seen in table 15, in this experiment, unlike the previous experiments, the in vitro HR was
significantly elevated at 4 hours. The effect on heart rate was entirely within the LPS
treatment. The graph below demonstrates that treatment with reserpine did not abolish this
difference in heart rate (figure 46).
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Figure 46. In vitro HR response four hours after endotoxin (LPS, 5 mg/kg) or NS treatment
in vivo. Animals had been pretreated with reserpine (RES 1 mg/kg) or sham vehicle 32 and 8
hours prior to LPS.
It is likely that this elevation in intrinsic heart rate was observed at four hours after endotoxin
treatment because the analysis of individual treatments and interaction between treatments
effectively doubles the n to 15- 16 animals per group when compared to experiments with
only 7 –8 animals per group. In other words, in the previous experiments there was a trend
toward the elevation of intrinsic heart rate a 4 hours but the sample size was insufficient to
have adequate statistical power to detect it. This suggests that the intrinsic heart rate may
begin to become elevated around 4 hours. It is more difficult to explain why reserpine did
not prevent the elevation of in vitro HR in this experiment. One possibility is that LPS
induces an increase in the regulation of intrinsic heart rate which requires the presence of
catecholamines to become manifest. If at four hours there was still incomplete depletion of
catecholamines by reserpine the in vitro HR would be elevated but by 16 hours with
depletion of catecholamines complete the reserpine-LPS heart rate has returned to control.
As will be discussed below, in this scenario the order and mechanism by which the βAR and
LPS and/or cytokines generate the elevation in IHR is unclear. What is clear is that both
mechanisms are required for the development of the persistent elevation in HR.
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DISCUSSION
Tachycardia is a ubiquitous finding in sepsis and endotoxemia. This increase in heart
rate is largely viewed to be a compensatory response of the autonomic nervous system to
hypotension and tissue hypoxia. The tachycardia of sepsis, however, develops slowly in
comparison to changes in blood pressure, lasts longer than the hypotension, and even
continues after the patient or animal is volume resuscitated. These findings suggest that the
tachycardia of sepsis is not baroreceptor mediated (Qi et. al., 1991; Yu et. al., 1997; Zhou et.
al., 1991). Certainly, chemoreceptors in the aortic and carotid bodies, as well as those in the
medulla, which sense hypoxia or hypercarbia could also play a role in increasing heart rate
(Levick, 1995). It is interesting to note that the tachycardia of sepsis is observed and even
increases, after plasma catecholamines reach their apex and plateau or decline (Jones and
Romano, 1989). When attempting to determine the origins of this tachycardia an even
greater paradox is that many investigators have demonstrated that the decrease in myocardial
contractile performance in sepsis is, in part, related to dysfunction or desensitization of the
β1-adrenoceptor (Bensard et. al., 1994; Jones and Romano, 1990; Werdan et. al., 1991). If
this is the case, and the same class of βARs that mediate inotropy also mediate chronotropy,
the question arises, why is tachycardia observed rather than bradycardia? There has been
reported evidence to suggest that the tachycardia is non-autonomic in origin. It has been
demonstrated using analysis of heart rate variability that during the tachycardia of
endotoxemia there is a decrease or absence of sympathetic input to the heart (Garrard et. al.,
1993; Godin et. al., 1996; Goldstein et. al., 1995). Other investigators have suggested that
calcitonin gene related peptide may play a role in the cardiovascular derangements of sepsis
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including tachycardia (Arden et. al., 1994; Huttemeier et. al., 1993). All of these findings
allude to the possibility that the tachycardia of sepsis may be intrinsic to the heart itself.
The fact that the heartbeat is myogenic, or intrinisic, in origin is no longer a matter of
debate, nor is the central role that the autonomic nervous system plays in regulating the rate
of the heartbeat. What is less recognized is that, in certain situations, the intrinsic rate at
which the heart beats can be altered. The IHR has been found to be decreased with age, and
exercise training has been shown to lower the IHR in both animals and humans. At this time
there is no widely recognized state in which the IHR is increased. A pharmacologic method
of determining the intrinsic heart rate was first proposed in 1966 (Jose et. al., 1966) and has
been used extensively since that time. Obviously, the excision and perfusion of the isolated
heart also provides a means of studying the intrinsic heart rate.
Given these two observations, one, that there are incongruencies in the literature with
regard to the mechanism of tachycardia in sepsis, and secondly that there is a predetermined
intrinsic heart rate that can be altered in certain physiologic conditions, the following
hypothesis was formed: An elevation in the intrinsic heart rate contributes to the tachycardia
observed following the administration of endotoxin. The research conducted to test this
hypothesis sought to answer three questions: (1) Is there an elevation of the intrinsic heart
rate in sepsis? (2) How is the elevation of IHR initiated and maintained? (3) Is there a
differentiation between the inotropic and chronotropic responses to sepsis? The results
clearly answer the first and third questions in the affirmative. With regard to the second
question, the initiation and maintenance of the elevation in IHR, the current findings suggest
that there is a requirement for both βAR stimulation and LPS or another factor induced by it.
The cellular mechanism by which this occurs remains to be further defined.
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In order to characterize the model of endotoxemia used, a single intraperitoneal
injection of endotoxin (5 mg/kg) followed by the observation of cardiac function 16-20 hours
later, we first examined in vivo HR and blood pressure changes over a 24 hour time course.
In this model, endotoxin caused no significant changes in blood pressure. This is not an
uncommon finding in the literature particularly with lower doses, endotoxin administered in
ways other than an intravenous bolus, and in cecal ligation and puncture models (Fish et. al.,
1985; Lubbe et. al., 1993; Palsson et. al., 1988; Shepherd et. al., 1987; Smith et. al., 1986).
Additionally, the in vivo heart rate did not become elevated until four to five hours after the
administration of LPS and remained elevated thereafter through the end of the monitoring
period. The experiment examining heart rate variability had similar findings. This delay in
the development the tachycardia is also not surprising. There is a lag time after the i.p.
injection of endotoxin before endotoxemia develops. With a 5 mg/kg dose of endotoxin,
plasma endotoxin levels do not plateau until two hours after administration and remain
elevated for five hours (Baharami et. al., 1993), cytokine production takes additional time,
with a peak of TNF at 30 minutes to one hour and IL-1 and IL-6 peaks between two and four
hours following exposure to LPS (Ayala et. al., 1992; Dunn, 1994; Kunkel et. al., 1994).
Because of this delay a slowly developing tachycardia is a common observation (Jones and
Romano, 1989). In the current study, the animals were clearly ill by four to six hours based
upon their toxic appearance. At sixteen hours the endotoxin treated animals were observed
to have lost 4.8% of their body weight. This finding, the loss of body weight, provided a
consistent means of assessing the effectiveness of the endotoxin administration.
In characterizing the model we were particularly interested in the later time periods.
Although it is well documented that the administration of endotoxin results in myocardial
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dysfunction by four hours, it was not until after this that the heart rate became consistently
elevated. Many investigators utilize the relatively short time period of four hours, likely for
experimental convenience, when studying the effects of endotoxin on contractile function.
Our research suggests that at this time point it is possible that changes in IHR have not
occurred or are just being initiated. Other investigators, who use longer time courses to study
endotoxemia or sepsis, often do so in models that provide for the continual exposure of the
animal to endotoxin. While these models, such as cecal ligation and puncture, osmotic
minipumps, infected clots, and subcutaneous abscesses, are better duplicates of the human
septic process, they do not separate the long term effects of endotoxin and the adaptive
responses of the host from the acute effects associated with repeated exposure. This could be
an important distinction as one of the prevailing hypotheses in sepsis research at this time is
that a derangement in the balance of initially protective host responses to endotoxin causes
much of the morbidity and mortality associated with sepsis (Bone, 1996). Along these lines,
it has been our observation that those investigators who have found an elevation of the in
vitro HR have employed models that were longer in duration (Barker et. al., 1990; Fish et.
al., 1985; Muniz et. al., 1991, Smith et. al., 1986). Because an elevation in the IHR was of
specific interest, and we felt it to be a slowly developing effect of endotoxin, a model that
observed cardiac function 16-20 hours after a single bolus LPS injection was used.
Pharmacologic antagonism of both the sympathetic and parasympathetic input to the
heart in vivo provides an estimate of the IHR. Furthermore, by determining the individual
effects of atropine and propranolol the relative inputs of each system to the heart rate can be
determined. In this rat model of endotoxemia we found the in vivo HR to be increased by
19% over controls. Interestingly, the relative effects of the sympathetic and parasympathetic
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systems were equal in both the control and septic animals. The IHR of the septic animals
was 21% greater than control animals. As confirmation of these findings we also observed a
23% difference in the heart rates of control and endotoxin treated animals when exposed to
the ganglionic blocker hexamethonium. These experiments confirmed the hypothesis that
there was an elevation of the IHR in sepsis and further suggested that the entire increase in
HR, on a percent basis, was due to the elevation of IHR rather than a modification of neural
regulation. In agreement with this, the studies of heart rate variability did not show a
significant alteration in the relative levels of autonomic input to the heart, despite a
significant decrease in total variability.
The possibility remained at this point that the difference in heart rate observed after
the administration of these drugs was related to humoral substances that were either products
of the autonomic nervous system, or were not “classic” autonomic neurotransmitters such as
CGRP or other neuropeptides. Excision of the hearts and perfusion in oxygenated buffer
should remove the heart from the influence of all humoral substances. When this experiment
was conducted we consistently observed a 15-20% higher in vitro HR of the rats treated in
vivo with endotoxin 16-20 hours earlier. The heart rate remained elevated for at least one
hour in this preparation. This percent increase in in vitro HR closely agrees with what others
have found (Fish et. al., 1985; Romanosky et. al., 1986; Smith et. al., 1986) and is
remarkably consistent with the in vivo changes that were seen in this study. These
observations exclude the possibility that the elevation in IHR requires the continuous
presence of another “hormone” like CGRP, adrenomedullin or angiotensin.
It is equally important to rule out the possibility that the elevation in IHR is caused by
any of the other previously described mechanisms delineated in the introduction. The
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Bainbridge or Anrep effect can be excluded for several reasons. The preparation used is an
isolated working left heart preparation in which buffer distends the left atrium and is pumped
into the ventricle and then ejected. The left atrial pressure is constant at 15 cm in both
control and endotoxin treated hearts. If the left atrium is more compliant in septic animals, it
is possible that it is stretched further (contains greater volume for a given pressure) than the
atrium of control animals. The Bainbridge response is elicited by the act of stretching not the
degree of stretch. With constant pressure, although there may be increased distension of
compliant atria, there is no mechanism by which the degree of stretch is altered and so the
Bainbridge response would not occur. More importantly, the Bainbridge response can be
excluded because this response is not present in the left atrium and the right atrium is not
perfused in this preparation (Jensen, 1971).
Alteration in temperature is another mechanism described to alter the intrinsic heart
rate (Knowlton and Starling, 1912; Walsh, 1969). Increases in temperature result in
increases in HR directed by mechanisms outside of the autonomic nervous system. In
examining the core temperature of ten rats that had been treated with LPS or saline we did
observe a significant difference. LPS treated animals had a mean temperature of 37 ± 0.12°
C versus 35.9 ± 0.12°C for control animals. These observations were made in anesthetized
animals and were anticipated, as LPS is a pyrogen. It is unlikely that this small difference in
temperature could have accounted for the difference in intrinsic heart rate in vivo (Walsh,
1969). The question is moot with regard to the observed difference in in vitro heart rates
because the buffer and apparatus were heated to the same constant temperature for both
groups of animals. Changes in osmolality and ion concentrations occur in sepsis and can
effect heart rate. While it is possible that these factors could have played a role in producing
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the observed difference in in vivo intrinsic heart rate, they can not account the in vitro
observations because the large volume of physiologic buffer with which the hearts were
perfused would abolish any differences in ion concentration. This is not to say, however, that
alterations in ion channel conductance or membrane permeability are not playing a role in the
elevation of IHR. In fact a decrease in the resting membrane potential (RMP) of rat
ventricular myocytes from –74 mV to –68 mV 18 hours after cecal ligation and puncture has
been demonstrated (Wu et. al., 1993). This type of change in RMP, if also occurring in
pacemaking cells, would decrease the time to depolarization and provide a potential
mechanism for the increase in IHR.
Although alluded to elsewhere in this work, a detailed discussion of the possible
reasons why we have observed an elevation in the IHR in sepsis where others have not is
appropriate. The first point is that others have made this observation (Barker et. al., 1990;
Fish et. al., 1985; Muniz and McDonough, 1991; Smith et. al., 1986). Fish and co-workers
found this observation so unusual that they included the following in their discussion:
“The reason for this in vitro tachycardia after 6 hr of endotoxin infusion is unknown,
but cannot be attributed to systematic experimental error. The rates were appreciably
higher than routinely recorded in this laboratory, and were observed under the same
operating conditions as controls (i.e., the same apparatus and buffer; control and
endotoxin hearts on the same day).” (Fish et. al., 1985)
Other investigators have seen differences in rate but did not have sufficient experimental
power to show statistical differences (Romanosky et. al., 1986). Furthermore, because most
experiments were designed to study contractile rather than chronotropic changes, and
therefore, hearts were subjected to electrical pacing, which would mask any differences in
HR that may have existed. Additionally, our model is somewhat different in that it
documents the prolonged effects of a single dose of endotoxin. Lastly, the sepsis literature
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has repeatedly demonstrated a tachycardia simultaneous with autonomic dysfunction or βAR
dysfunction which strongly suggest an elevation of IHR.
There is evidence in the experimental results presented for two factors, besides LPS,
which significantly altered the IHR. The first is the relationship between weight and HR that
indicated that the IHR declined by 0.2 beats per minute with each gram increase in body
weight. The effect of increasing heart weight on IHR has been reported (Harri and Kuusela,
1982). Because rats grow at a constant rate it is likely in this instance that the increase in
weight served simply as a marker for increasing age which has also been demonstrated to
result in a decrease in IHR in the rat (Kreider et. al., 1984). The other effect, that of
anesthetic, is less well described. Pentobarbital was found to decrease the IHR in both LPS
and control animals by 15% when compared to Telazol. While it has been noted that
pentobarbital can exacerbate endotoxin induced myocardial contractile dysfunction in rats
(Hoque et. al., 1996), its effects on HR are less clear. Some investigators have reported that
pentobarbital anesthesia induces an increase in in vitro HR and improvement of in vitro
myocardial performance over decapitation (Rubanyi and Kovach, 1980; Sage et. al., 1985)
others have found the opposite (Segal et. al., 1990). No studies examining the effect of
Telazol on in vitro cardiac function in rats have been found to date. In large animal studies
the drug has been shown to have minimal effect on in vivo cardiac performance (Lin et. al.,
1991). It is especially important to note, however, that neither of these observations affected
our experimental findings, as the effects were constant across both the LPS and control
treatment groups regardless of the anesthetic employed.
The second question which the experiments sought to answer, is related to the
mechanism of induction and maintenance of the increase in heart rate. When the
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catecholamine content of the rat was depleted by pretreatment with reserpine prior to
endotoxin administration the elevation of the IHR was abolished. This effect could be
explained via several mechanisms. One obvious possibility is that catecholamines are
required to initiate the elevation in IHR. Catecholamines, are, however, clearly not required
for the ongoing maintenance of the increased IHR as evidenced by the failure of propranolol
to abolish the elevation in IHR in vivo or in vitro when administered after endotoxin.
Alternatively, reserpine is somewhat nonspecific in its action and also depletes the nerve
terminals of other neurotransmitters, notably 5-hydroxytryptamine (5-HT), which has been
variably found to cause bradycardia and tachycardia (Dabire et. al., 1992; Cherqui et. al.,
1988). Another possibility is that reserpine was toxic to the myocardium and a component of
this toxicity affected HR. The toxicities of reserpine are well known (Casteels and Login,
1983; Wilcken et. al., 1967) and, although unlikely to occur at the doses used in these
experiments, this remained a plausible hypothesis. To confirm that the effects which
reserpine abolished are mediated by catecholamines, and more specifically through the βAR,
studies were conducted in which this receptor was antagonized prior to and during the
induction of endotoxemia. Bromoacetyl alprenolol menthane (BAAM), an irreversible βAR
antagonist, administered prior to and during the septic insult also prevented the increase in
IHR. This observation extended the findings of the experiments with reserpine to conclude
that the elevation in IHR observed in sepsis was mediated via catecholamines acting at the
βAR. It is noteworthy that when the hearts of the animals treated with BAAM were excised
at 16-20 hours and used to construct dose response curves to isoproterenol the βAR function
appeared to be normal.
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The experiments in which there is an elevation of the in vitro heart rate at four hours
after endotoxin administration following reserpine pretreatment but not at 16 hours makes the
interpretation of these findings somewhat more challenging. It is known that rats are more
resistant to the depleting action of reserpine than other small mammals such as the guinea pig
(Rice et. al., 1987). To fully deplete the animal of catecholamines, particularly the adrenal
medulla, often requires several administrations of relatively large doses of reserpine. It is
entirely plausible that these animals were not fully depleted of catecholamines at the time of
LPS administration and this remaining small releasable pool of catecholamines could provide
the basis for the intriguing observation. This would further suggest that LPS is required to
initiate the change in IHR but that βAR stimulation was required to maintain the effect. If
this were the case then the experiments conducted to examine the decay of the increased
heart rate should have demonstrated different decay rates for LPS treated animals regardless
of whether they had been pretreated with reserpine or not. In this experiment no significant
differences were observed between the maximal heart rates or finishing heart rates. The
experiment is somewhat inconclusive in that statistical differences were not observed in the
basal rates of the isolated atria and that none of the heart rates had returned to basal by one
hour after washout. Additionally the Sham-NS decrease in heart rate was steeper than the
other three groups. There was, however, no difference between the reserpine-NS and
reserpine-LPS groups. On the basis of this experiment the hypothesis that both effects (βAR
stimulation and LPS) are required early in the septic process to initiate the change in IHR can
not be excluded.
From the experiments of others, and our own observations, it is known that prolonged
stimulation of the βAR alone is not sufficient to elevate IHR (Matthews et. al., 1996;
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Nylander et. al., 1984). The current study demonstrated that activation of the βAR is crucial
in eliciting the elevation in IHR after LPS. Therefore, it is logical to conclude that the
elevation of IHR is caused by a cellular event that requires both LPS, or the cytokines it
induces, and stimulation of the βAR. When examining the time course over which the
elevation of IHR occurs there are several observations of note. The first is that the increase
in in vivo HR is not observed before four hours after LPS suggesting that there is a factor
involved which requires time to be produced or induced. The second is that in vivo HR
becomes elevated, and stays elevated, in the absence of substantive differences in blood
pressure suggesting the lack of involvement of baroreceptors and other reflexes. The third
observation is that the in vitro HR remains elevated and constant for at least one hour
following extirpation. The relatively long time course of all of these events points more
towards an alteration in protein synthesis than protein function. Figure 47 illustrates the
mechanisms by which βAR stimulation increases heart rate that have currently been
proposed. A change in protein synthesis, including an increase in synthesis, a decrease in
synthesis or altered synthesis, of any one or more of the proteins in this pathway could alter
the intrinsic heart rate.
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Figure 47. Normal signal transduction process used to increase HR. Norepinephrine (NE)
stimulates the βAR. Gs is activated and does one of two things, it activates (or inactivates)
channels and activates adenylyl cyclase. Four cAMP are required to bind the regulatory
subunits of PKA before the catalytic subunits are released these subunits can phosphorylate
ion channels to alter heart rate. All of the described channels are shown (Campbell et. al.,
1992). Both Gs and PKA have been shown to alter If to increase HR (Yatani et. al., 1990).
PKA is known to alter potassium channels (decrease conductance, Huang et. al., 1994) and
calcium channels (increase conductance, Haase, 1996).
PKA-C is the mechanism by which the βAR is known to signal to the nucleus. It is
also known that with increasing stimulation of adenylyl cyclase and PKA that PKA-C levels
ultimately decrease (Boundy et. al, 1998; Garrel et. al, 1997). Additionally PKA-C has been
demonstrated to be activated in the right atrium early in the septic process (Hsu et. al., 1997).
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In light of this, the amount of PKA in the right atrium at several time points after the
administration of endotoxin was examined. PKA-C levels declined to a third of control
levels by sixteen hours after endotoxin, suggesting that at some point prior to sixteen hours
there is likely to have been significant activation of PKA-C. The finding further
demonstrates that it is unlikely that ongoing βAR stimulation is responsible for the elevation
in IHR at sixteen hours. Measurement of PKA-C levels does not provide any information
which regard to the activity of PKA-C or the time course, if any, over which message is sent
to the nucleus. An examination of the levels of phosphorylated CREB demonstrated that
there is signalling to the nucleus (presumably through PKA-C) as early as two hours after
LPS and that this signal peaks at fours after LPS. Interestingly Phospho-CREB levels have
returned to control levels by 16 hours, again suggesting a possible early message to the
nucleus that may result in an elevation of IHR.
The following description provides an example of a potential mechanism underlying
the elevation of IHR for illustrative purposes. Assume that in order to increase HR, PKA
must phosphorylate a potassium channel thereby decreasing the hyperpolarization of the cell
and permitting an increase in HR. A protein phosphatase would remove this phosphate
group placed on the channel allowing the HR to return to normal. If endotoxin, in concert
with βAR stimulation were to decrease production of the phosphatase via a change in protein
synthesis the signal created by the phosphorylated channel would continue and HR would
remain elevated. However, in order for the HR to increase initially would require some
threshold of stimulation of the βAR resulting in PKA activation to cause a sufficient number
of channel phosphorylations to observe the increase in IHR. With reserpine administration
and depletion of catecholamines this threshold of activation may never be reached and the
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increase in IHR would not be observed. The administration of BAAM before endotoxin
could prevent either the reduction of the phosphatase, and / or PKA activation, thereby
preventing the increase in HR. There is some support for this proposed mechanism since
inhibition of phosphatases 1 and 2A has been shown to prolong by up to 4 hours the
decrease in potassium channel current induced by cAMP in mammalian neurons (Ansanay et.
al., 1995). In guinea pigs inhibition of PKA resulted in a lowering of the elevation of HR
induced by βAR stimulation, and inhibition of phosphatases 1 and 2A augmented the
response. Furthermore, HR appeared to be elevated in two manners, a slower response
phosphorylation and a faster response (presumably G-protein mediated) that was not related
to phosphorylation. This could suggest why there is not an alteration of the chronotropic
concentration response curve to isoproterenol after LPS despite the presence of decreased
levels of PKA –C. Interestingly these effects of βAR activation did not extend to inotropism
(Gotoh, 1995).
One consideration this proposed scheme addresses, that is not addressed in the
currently available results, is the site at which the signal produced by endotoxin, or
cytokines, and βAR stimulation interact. Is it at the level of altering protein transcription, or
does one signal modify transcriptional events and the other serve as the reinforcement to
perpetuate the change? One way to examine this question would be to administer
isoproterenol to endotoxin exposed animals pretreated with reserpine. Presumably the
alteration of, in this hypothesis, phosphatase production has occurred but PKA activity has
not reached the required threshold for the change to be observed. Isoproterenol administered
anytime after four hours would be predicted to cause sufficient PKA activation to result in a
lasting increase in the IHR. Although the results are somewhat inconclusive because none of
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the heart rates returned to baseline, the results of the experiment exposing isolated right atria
to isoproterenol after LPS and reserpine suggest that this is not the case and that both
mediators are required simultaneously.
Combining the available evidence from our experimental observations with the
hypothetical scheme presented above, one crucial prediction that emerges is that the ultimate
cellular mechanism involves an obligatory change in protein synthesis. For this to occur
there must be the transmission of an extracellular signal to the nucleus that involves or is
promoted by some combination of the βAR and / or LPS or cytokine signaling pathways. A
large body of evidence already exists demonstrating that βAR signal transduction not only
leads to rapid cellular responses but also that information is provided to the nucleus that
results in alterations in gene expression for long term regulation. The most well described
mechanism through which the βAR signals to the nucleus involves PKA-C. The elements of
this pathway are illustrated schematically in figure 48. Briefly PKA exists as an association
of two catalytic subunits and two regulatory subunits. Each regulatory subunit binds to
molecules of cAMP. After four cAMP molecules are bound the regulatory and catalytic
subunits dissociate. The catalytic subunit can now translocate to the nucleus where it
promotes the phosphorylation of CREB1. A CREB1 dimer is created by the combination of
phosphorylated CREB proteins this then binds to the CREB binding protein (CPB) which
activates the transcription factor cyclic AMP response element (CRE) (Boutillier et. al.,
1992; Cooper, 1997). Our current research, however, suggests that while βAR signal
transduction alone is necessary, it is not sufficient to cause the hypothesized alteration in
protein synthesis responsible for the increase in IHR. There apparently needs to be some
synergism between LPS or cytokine signaling mechanisms and the βAR mediated pathways.
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Identifying sites at which overlap between these signaling cascades exits should provide
direction for further investigation.
Several signaling pathways have been proposed for LPS and the cytokines including
the JNK(Jun N-terminal Kinase)/SAPK (Stress Activated Protein Kinase )/p38 MAP
(Mitogen Activated Protein) kinase cascades and the JAK-STAT (Janus kinase- Signal
Transducers and Activators of Transcription) pathway (see figure 48). In the MAP kinase
(MAPK) pathways a G protein is activated, usually via an extracellular receptor, which, in
turn, activates a cascade of serine-threonine kinases the last of which is capable of
translocating to the nucleus where it phosphorylates a ternary complex factor (TCF)
including Elk-1 and SAP1. The TCFs then form a complex with the serum response factor
(SRF) to bind the serum response element (SRE). Interestingly, both the SRE and CRE are
thought to require activation to transcribe the cFOS gene. JNK/SAPK (same pathway) also
phosphorylate JUN to activate this protein so that it can either homodimerize or
heterodimerize with FOS to form activator protein 1 (AP1) and p38 phosphorylates heat
shock proteins. The JAK-STAT pathway results in a STAT homodimer that can translocate
and activate transcription and JAK which can activate the G-proteins that simulate the
MAPK cascades (For recent review of these topics see Cano and Mahadevan, 1995; Curran
and Morgan, 1995; Cohen, 1997; Cooper 1997; Janknecht et. al., 1995; Kyriakis and Avruch,
1996; Ransohoff, 1998; Whitmarsh and Davis, 1996).
All of these pathways have been studied in the myocardium particularly in response
to the cellular stress of ischemia and stress resulting in myocardial hypertrophy (Bogoyevitch
et. al., 1996; Hefti et. al., 1997; Page and Doubell, 1996). Our results indicate that both βAR
stimulation and LPS or cytokine activity are required to increase IHR. It has not been
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demonstrated conclusively if either one or both messages go to the nucleus. If both signals
are transmitted to the nucleus it seems likely that there may be interaction between the two
pathways in order to increase IHR. These potential sites of interaction are illustrated in
figure 48.
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Figure 48. Figure represents some of the described mechanisms by which the βAR and
cytokines signal to the nucleus. Possible sites of interaction include at the CRE and SRE
promoter sites for the cfos gene, both of which are required for transcription. Interaction at
the site of release of CREB1 from CREB2 binding has been proposed as a mechanism of long
term potentiation (Bailey et. al, 1996). Also there could be interaction after the
phosphorylation of Jun and Fos to form the activator protein 1 (AP1) which returns to the
nucleus to induce further transcriptional changes.

The last question which these experiments sought to answer was the relationship, if
any, between inotropic and chronotropic changes during the development of sepsis. Our
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results demonstrated that there was a significant decrease in contractile performance at four
hours but not at 16 hours following LPS administration. The converse was demonstrated
with regard to an elevation in IHR, which was not elevated at four hours but was at 16 hours
after endotoxin administration. The findings of contractile dysfunction at four hours confirm
the findings of others using similar doses and time courses. The work presented here further
demonstrates that in the rat an elevation in HR is associated with a worsening of contractile
performance. What is particularly interesting is the finding of an elevation in IHR after the
contractile dysfunction has returned to normal. This raises several teleological questions.
Would it be beneficial for the organism to have a mechanism whereby it could increase its
IHR? Is this response purely pathological or is it a normal compensatory response gone
awry? These questions can probably never be fully answered nor is it the author’s intent to
return to the metaphysical discussion of heart rate we left behind some 300 years ago. The
organism increases HR via the autonomic nervous system when it requires an immediate
increase in the delivery of oxygenated blood. The increased demands in terms of oxygen and
energy requirements, however, make this a costly compensation. Additionally, as was
discussed earlier, in many situations the increase in HR jeopardizes contractility resulting in
either no net change or a diminution of cardiac pump function. In this scenario the increase
in HR, the price of which could ultimately jeopardize the heart itself, results in little gain.
The detrimental effects of this elevation are particularly evident when the HR is elevated for
a long period of time. Conversely, the heart, unlike other organs, is perfused exclusively in
diastole. Perfusion pressure is therefore dependent on the mean pressure and the ratio of the
decay time of aortic pressure in diastole and the duration of diastole. The decay time is
predicted by arterial compliance. As peripheral resistance decreases the decay time
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decreases. In situations like sepsis where there is a marked reduction in the systemic
vascular resistance the diastolic pressure therefore decays more quickly, and perfusion
pressure rapidly decreases. One way the heart could accommodate for this reduced perfusion
would be to increase HR (decrease the heart period) to maintain diastolic pressure. This has
been postulated to be the reason for the differences in HR in mammals and why smaller
animals tend to have much higher heart rates (Westerhof and Elzinga, 1993). In this case an
intrinsic increase in heart rate would spare the organism from having to continually produce
neurotransmitter to increase HR. Is an elevation of IHR a long term means of adaptation and
the autonomic nervous system a short term system of accommodation? Along these lines,
others have postulated that sinoatrial node may act as a servomechanism (James, 1973). By
resetting the servomechanism to a higher IHR less autonomic stimulation would be required
to achieve the same result.
While the benefits of decreasing the intrinsic heart rate following exercise training are
clear the benefit of an increase in IHR are less so. Our experiments found that increasing the
heart rate outside of the autonomic nervous system jeopardized contractility and jeopardized
cardiac pump function. Direct extrapolation of rat heart rate observations to the human is
fraught with more problems than the usual interspecies comparison because the existence of
a positive force-frequency relationship in the rat is a matter of some debate. There are,
however, pathologic states similar to sepsis where increasing heart rate in the human results
in a decrease in force of contraction (Schmidt et. al., 1995; Just, 1996). Additionally, if the
βAR is dysfunctional, as many have proposed, and the increase in HR involves mechanisms
outside the autonomic nervous system, any increase in rate in the human would likely
decrease the force of contraction. The suggestion that a long term tachycardia may be
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detrimental to the organism is increasingly recognized. In disease states in which there is a
prolonged elevation of heart rate, such as hypertension, congestive heart failure and burns,
the use of beta-blockers to slow rate is increasingly being advocated. Burned children treated
with propranolol show a decrease in heart rate by 10 to 16% with no effect on blood pressure
or tissue perfusion (Baron et. al., 1997). In patients with congestive heart failure the latest
generation β-blocker, carvedilol, has been demonstrated to decrease mortality by 65%,
although its mechanism of action is unclear (Feurerstein et. al., 1997). Heart rate also been
shown to be an important predictor of hypertension and of greater importance a major risk
factor in predicting cardiovascular and noncardiovascular death (Habib, 1997; Palatini and
Julius, 1997). In a prospective study of operative patients, those treated with atenolol in the
perioperative period were shown to have a decreased incidence of cardiac deaths up to two
years later (Mangano et. al., 1996). These studies, and our own experimental observations
demonstrate that in situations of stress on the myocardium tachycardia can contribute to
significant morbidity and mortality. Because the IHR appears to function as a set point that
is further regulated by the autonomic nervous system, β-blockers could effectively lower HR
(though not IHR) in septic patients. Whether this therapy could beneficially be extended to
sepsis is unknown. Experimental evidence has suggested that sympathetic denervation,
either chemically or surgically, is protective to end organs, and decreases mortality in sepsis
(Bolton and Aluk, 1978; Filkins, 1979; Palmerio, 1963; Zetterstrom, 1964). We observed no
decrease in mortality with reserpine pretreatment. Parker’s group found in human sepsis that
a lower initial HR (<106), a decrease in HR in the first 24 hours by greater than 18 beats per
minute, or a 24 hour HR of < 95 are predictive of survival. This normalization of HR was
coupled with a return of the stroke volume index towards normal. The authors’ speculated

137

that this “probably represents a normalization of the peripheral cardiovascular abnormality
which led to a high HR” (Parker et. al., 1987). Our research suggests that an alternative
hypothesis would be that those patients with an elevated HR might have had an ongoing
pathologic elevation of IHR. Besides sepsis we know of one other disease process in which
there may be an elevation of IHR. In the syndrome of “inappropriate sinus tachycardia”
there is supersensitivity to βAR agonists and a 30% elevation of IHR (Morillo, et. al., 1994).
The cause of this disease process is unknown.
In conclusion, the importance of the heart rate in human disease states has been
recognized since the time of the earliest medical recordings. That the heart beat is not
dependent upon nervous input and is instead myogenic in origin is no longer the subject of
debate. More recently, interest in determining the intrinsic heart rate, or the rate without any
nervous or humoral input, has developed. These experiments have led to the discovery that
the IHR is decreased with age and exercise. This dissertation proposes the first inducible
disease state, to our knowledge, in which the IHR is elevated, sepsis. In addition our work
further implicates the βAR as a necessary participant in the induction of the increase in IHR
but also demonstrates that the change outlasts the ongoing stimulation of this receptor and yet
a persistent elevation in IHR remains. Further work has been proposed to identify the signal
to the nucleus that we hypothesize must occur to alter protein synthesis and induce this
change in intrinsic heart rate. The apparent complexity of this process leads us to often agree
with Harvey as he noted in 1628:
‘When I first tried animal experimentation for the purpose of discovering the motions
and functions of the heart by actual inspection and not by other people’s books, I
found it so truly difficult I almost believed with Fracastorius, that the motion of the
heart was to be understood by God alone.’
William Harvey, MD
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